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Purpose:  Electron skin collimation (eSC) sharpens the penumbra, allowing electron 
radiotherapy of cancers while minimizing dose to adjacent normal tissue, e.g., protecting the eye 
in treating eyelid and nose cancers. This study assessed the clinical potential for milled brass 
eSCs to replace manually-fabricated lead or Cerrobend eSCs.  
Methods:  Aim one was to measure the influence of eSC edge angle on the dose distributions, 
which were measured under edges of lead eSCs for combinations of three bevel (0°,±10°) and 
five gantry (0°,±3°,±5°) angles for a 6-MeV beam. Aim two was to validate the dimensional 
conformity of three machined brass eSCs, one designed for a cylindrical phantom and two for an 
anthropomorphic head phantom. eSC shapes were compared using megavoltage computed 
tomography (MVCT) of brass eSCs, kilovoltage computed tomography (kVCT) of wax replicas, 
and physical measurements. Aim three compared dose distributions in the cylindrical phantom 
for a brass eSC (≈ 7×9 cm
2
) with those for lead and Cerrobend eSCs at 16-MeV. All dose 
distributions were the average of three radiochromic EBT2 film measurements. 
Results:  Aim one showed all combinations of (0°,±10°) bevel and (0°,±3°,±5°) gantry angles to 
have insignificant effect on penumbral width (≈ 0.5 mm). Increased dose from scatter, as great as 
11% near the edge, was clinically insignificant because of low surface dose for 6 MeV beams 
and insignificant change in R90. Aim two showed MVCT, kVCT, and physical measurements 
useful for quality assurance. Also, it revealed that distal eSC surfaces matched designs (≤ 2 mm), 
that thicknesses deviated ≤ 1.5 mm from design, and that two of three eSCs had aperture edges 
focused ≈20 cm above the eSC generating errors up to 3 mm. Aim three showed the brass eSC to 
have comparable radiation leakage, penumbral width, field width, and coverage of distal 90% 
dose contour, but increased scatter dose (3-10%). 
xi 
 
Conclusions:  Results indicated that machined brass eSC holds good potential for replacing lead 
or Cerrobend eSCs. Prior to clinical utilization, two recommendations are (1) to eliminate the 
cause of incorrect divergence in the aperture edges and (2) to determine the bevel angle that 
minimizes scatter dose from brass eSC edges.
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Chapter 1:  Introduction 
Skin cancer is a major health care problem in the United States; in 2010 and 2011, 
approximately 75,000 new cases of skin cancers were diagnosed, resulting in nearly 12,000 
deaths (Jemal et al. 2010; Siegel et al. 2011).  With the departure of orthovoltage x-ray machines 
from the clinic, as Co-60 and linear accelerators became the machine of choice in the 1960s and 
1970s (Brahme 1987), electron therapy became an essential clinical modality for the treatment of 
skin and other superficial cancers.  Some of the advantages of this treatment modality include a 
characteristically high surface dose, a sharp surface dose buildup (<10 mm) of delta rays, a 
relatively uniform dose plateau as dose slowly builds up due to multiple Coulomb scatter, and a 
steep distal dose fall-off (Hogstrom 2003).  Electrons have been used to treat cancer target 
volumes within 6 cm of the surface, primarily in the head, neck, and chest wall (Hogstrom 2003).  
These include superficial or skin lesions, involving basal cell and squamous cell carcinomas 
(primarily of the head and neck) (Tapley 1976), total limb electron irradiation (Wooden et al. 
1996), and total skin electron irradiation (TSEI) for the treatment of mycosis fungoides 
(Karzmark et al. 1987; Khan et al. 1991).  The function of skin collimation in electron therapy is 
to minimize the penumbra when treating in close proximity to critical structures, which is 
especially important for low energy electron beams, small fields, extended treatment distances, 
using bolus (on or off the patient surface), and using arc therapy (Hogstrom 2003). 
Electron skin collimation (eSC) is often used in the head and neck region due to the 
typically small field size, as well as the proximity of critical structures to the treatment volume 
(Hogstrom 2003).  For small field sizes, eSC sharpens the penumbra allowing better dose 
homogeneity and, as a result, improves coverage of the therapeutic region (i.e., within the 90% 
dose contour), as shown in Figure 1.1 (Hogstrom 1991).  As such, the treatments of small lesions 
2 
 
(e.g., on the eyelids and inner canthi) can be significantly enhanced with the incorporation of 
eSC (Tapley 1976).  Bolus is frequently used in the treatment of the nose due to the irregular 
surface of the nose and tissue inhomogeneities, and in such cases, eSC is often used to restore 
penumbral sharpness beneath the bolus (Million et al. 1991) (see Figure 2.3). 
 
Figure 1.1:  Comparison of dose distributions for a 6 MeV, 3×3 cm
2
 beam.  (a)  A larger field 
size is reduced to a 3×3 cm
2
 field size using eSC.  (b) The 3×3 cm
2
 field size is collimated by the 
treatment head collimators (10 cm air gap), which results in diminished penumbral sharpness and 
a reduction of the coverage of the 90% dose region (Hogstrom 1991). 
Despite the improvements made by eSC in certain situations, utilization of eSC remains 
somewhat limited because of challenges associated with its on-site fabrication (e.g., time, labor, 
expertise, cost, and toxicity of materials).  Additionally, with the widespread incorporation of x-
ray multi-leaf collimators (xMLC) on linear accelerators, the number of mould rooms dedicated 
to the fabrication of in-house collimation (x-ray blocks) and treatment aids (compensators) has 
dwindled.   In an effort to expand the availability and convenience of electron skin collimation, a 
commercial medical device manufacturer (.decimal, Inc., Sanford, FL) is developing the 
capability to provide custom skin collimators milled from brass whose shape is based on patient-
specific CT data.  Prototype eSCs are manufactured from brass using a computer numerical 
control (CNC) milling machine.  The eSC can be designed relatively easily within a commercial 
Treatment Planning System (TPS), and the coordinates of the skin collimator contours, based on 
the CT coordinate system, can be used to generate data electronically delivered to the eSC 
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manufacturer for machining.  An eSC requires approximately an hour to design and upload to the 
manufacturer.  The manufacturer should be able to mill the eSC and mail it to the clinic within a 
24-48 hour time period at a reasonable cost.  Comparatively, approximately 12 hours of clinical 
staff time is required for in-house design and construction.  In principle, milled collimators 
should be more accurate than in-house fabrication (i.e., better fit the patient surface, more exact 
aperture shape, and more uniform thickness than Cerrobend).  However, the literature does not 
contain any reports on the dosimetric performance of a third-party milled eSC device.   
The practice at our clinic (Mary Bird Perkins Cancer Center) has been to construct 
Cerrobend skin collimators with “open” beveled edges defining the aperture.  “Open” beveled 
edges, as compared to straight edges, allow fine tuning of the gantry angle (±5°) by the radiation 
oncologist after fabrication without modifying the projected electron field on the patient and also 
should prevent small rotational setup errors from having a substantial dosimetric impact.  With a 
straight edge, the upstream surface of the skin collimator will define the edge on the side of the 
eSC to which the gantry is rotated (e.g., a 5° rotation will shrink the field edge positioned on 
central axis by approximately 1 mm for an eSC with a thickness of 1 cm), while on the opposite 
side of the eSC, the number of electrons grazing the collimator edge increases.  Although “open” 
beveled eSC edges removes the former issue, it increases the number of electrons grazing the 
collimating edge surface, which further impacts the collimator-scattered electrons striking the 
patient.  Verhaegen et al. (2001) reported some results of how the electron dose distribution is 
perturbed by the presence of eSC, particularly near the eSC aperture edge and under the eSC.  
Near the eSC edge, a lobe of increased dose is formed by scattered electrons at a seemingly 
predictable angle relative to the nominal beam direction at the surface.  Based on Monte Carlo 
calculations, their results showed that, in general, a decrease in electron beam energy caused an 
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increase in the angle of the lobe of increased dose and that this effect is almost independent of 
eSC thickness.  The literature contains some other studies that address electrons scattering at a 
collimator edge (Beardmore 2007; Chi et al. 2005; Lax and Brahme 1980), but the applicability 
of these studies to optimizing the design of eSCs is limited.  As such, there is incomplete 
knowledge of the dosimetric impact of the selection of the edge angle of collimators for the 
treatment of skin lesions. 
The purpose of this study was to evaluate the potential for a commercial device 
manufacturer to mill brass skin collimators that are clinically acceptable (i.e., comparable or 
better than skin collimators of lead or Cerrobend currently being fabricated in-house).  One key 
eSC design feature, the angle of the aperture edges and its effects on the dose distribution via 
collimator scatter, will be examined.  Also, dosimetric features of a milled brass eSC will be 
compared with that of lead eSC and Cerrobend eSC that were fabricated using the current in-
house methods.  The results of this study will be important because they should provide 
information useful for determining the clinical potential of a milled brass eSC system.  
The hypothesis of this project was [1] that a third-party milled brass eSC, with its 
collimating edge parallel to the mean direction of the divergent electron beam, can be milled 
accurately, i.e., within design parameters and [2] that it will be dosimetrically equivalent to 
current lead and Cerrobend eSCs, with edges parallel to the beam central axis and an open bevel 
angle of 10°, respectively.   
For [1] “accuracy” was assessed using the following criteria: 
 eSC brass thickness will agree with design thickness within ± 1 mm. 
 Distal surface of the eSC will agree with the skin surface within 2 mm. 




For [2], dosimetric equivalence was assessed using the following criteria: 
 Change of R90 on central axis will be ≤ 1 mm 
 Change in maximum dose value will be ≤ 5%  
 Change in penumbral width (P80-20) will be ≤ 2 mm 
This hypothesis was tested by completing the following specific aims: 
Aim 1:  Measure the influence of collimator edge angle on the properties of dose 
distribution.  The influence of the collimator edge angle (0°, ±10°) on the lateral penumbral 
width and dose uniformity in a simple, homogeneous, box-shaped phantom was evaluated for a 6 
MeV electron beam with multiple gantry angles (0°, ±3°, ±5°). 
Aim 2:  Validate the dimensional conformity of the machined brass eSC to the planned eSC 
design.  The dimensional accuracy of the machined eSCs (thickness, shape of the distal surface, 
and shape of the aperture) was examined using an MVCT fusion of the brass eSC as well as a 
kVCT fusion of a wax replica of the brass eSC with the design.  Also, manual measurements 
were used.  Results were compared with the design shapes determined by the TPS.  Calculated 
distances within the CT coordinate system were used to verify design conformity and also to 
discern any observable differences in the CT fusions from potential imaging artifacts. 
Aim 3:  Evaluate the dosimetric performance of a machined brass eSC and compare to that 
for the current standard of care (lead or Cerrobend eSC).  The results of dosimetric 
validation tests, which were collected using collimators fabricated according to the current 
standard of care (Cerrobend collimation and lead collimation fabricated in-house), as well as the 
proposed standard of care (milled brass collimators fabricated off-site), were compared to assess 
dosimetric equivalence of the collimating materials.  Dosimetric performance was evaluated by 
measurement of the dose distribution in a cylindrical phantom for a 16 MeV electron beam 
incident on an irregular eSC aperture (≈ 7×9 cm2).  
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Chapter 2:  Properties and Techniques for Fabrication of eSCs 
2.1 Determination of Skin Collimator Attributes for Clinical Use 
2.1.1  Skin Collimators Made from Lead 
A significant portion of electron skin collimators (eSCs) used for electron radiotherapy is 
manually fabricated using multiple thin sheets (≈1.5 mm) of lead.  Lead (Z = 82, ρ = 11.34 
g/cm
3
) is well suited for skin collimator fabrication due to its relatively high linear stopping 
power and malleability at room temperature.  This malleability facilitates fabrication of electron 
skin collimation (eSC) that closely follows the contour of the patient’s surface.  Due to the 
hazardous nature of lead to humans, handling precautions must be observed and guidelines must 
be followed at the time of its disposal.  Since skin collimators serve to shape the electron beam 
incident on the patient, the collimator must be of sufficient thickness to stop the primary 
electrons, i.e., reduce the transmission of dose to the expected level of bremsstrahlung outside 
the collimator’s aperture.  To determine this minimum thickness, tPb, the following equation was 
utilized:  
    [  ] ≈ (
    [   ]
 
)   ,                                                         (2.1) 
where Ep,0 is the most probably electron beam energy at the surface (Khan et al. 1991).  This 
“rule-of-thumb” applies to the interval of clinically utilized electron beam energies (4 to 20 
MeV). 
 The shape of the treatment field is delineated by the physician, using either CT data or 
patient anatomy.  The aperture shape of the eSC is then produced based on the specifications of 
the physician’s drawing.  The eSC is fabricated using the following process:  first, using mould 
technique (e.g., Watkins (1981)), a plaster stone bust positive of the region of the patient 
containing the treatment field was created that included the area to be irradiated.  The treatment 
7 
 
field was then directly drawn on the patient-surrogate by the physician, or in some cases, it was 
drawn on the patient, for which case it was carried through in the moulding process (Watkins 
1981).  A ball-pein hammer is typically used to conform the lead eSC to the contour of the 
patient surface. 
 Using the physician-defined aperture shape, the aperture was cut from a number of lead 
sheets.  The eSC was laterally extended to intercept the penumbra formed by the upstream 
collimation, consisting of an electron applicator with or without an applicator insert (Hogstrom 
2003) (Figure 2.1).  The malleability of lead makes precise dimensional accuracy of the aperture 
difficult to achieve.  The lead eSC edges are usually approximately perpendicular to the patient 
surface due to the lack of precision in common fabrication methods, and the outer portion of the 
eSC is sometimes flared away from the patient surface (see Figure 2.2), typically to 
accommodate patient setup and improve comfort.  Two clinical examples are shown in Figures 




Figure 2.1:  eSC lateral extention. (a) A side view of a hypothetical treatment setup shows the 
larger field formed within the treatment head that is further reduced downstream by the eSC.  A 
beam’s eye view is shown in (b) to further illustrate that the eSC should be laterally extended to 




Figure 2.2:  Clinical example of scalp irradiation incorporating lead eSC and an acrylic scatter 
plate (Hogstrom 1991). 
 
Figure 2.3:  Clinical example of whole nose irradiation using lead eSC to collimate the beam 
beneath tissue-compensating bolus (Million et al. 1991).  Shown are the lead eSC on the patient 
without bolus (upper-left), the bolus placed on top of the lead eSC (lower-left), and an 
illustration of the expected impact of the bolus on the dose distribution (right) without eSC. 
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2.1.2  Skin Collimators Made from Cerrobend  
In addition to lead eSC, Cerrobend (MT-A158, MED-TEC, Orange City, IA), or 
Lipowitz’s alloy, is commonly utilized as an eSC material.  This is due to Cerrobend’s low 
melting point (158°F), which allows for easy casting of the material.  To fabricate Cerrobend 
collimation, molten Cerrobend is poured into a mould and becomes rigid as it cools to room 
temperature.  This rigidity allows for precise shaping of the eSC edges with the use of a rotary 
machining tool.  Cerrobend is an alloy of bismuth (50%), lead (26.7%), tin (13.3%), and 
cadmium (10%), with an effective atomic number (Zeff) of 76.8 and density of 9.4 g/cm
3
.  To 
determine the required Cerrobend collimator thickness (tCerr) to adequately shield proximal 
healthy tissues, a modified form of Equation 2.1 was used: 
         (   )                                                              (2.2) 
The 20% increase in the required thickness of the Cerrobend, compared to lead, comes from the 
ratio of the density of lead (11.3 g/cm
3
) to Cerrobend (9.4 g/cm
3
) (Khan et al. 1991). 
In contrast to lead collimators, which typically had edges parallel to the beam central 
axis, our clinic has traditionally preferred for Cerrobend eSC to have a “positive” (convergent) 
bevel angle (Figure 2.4).   
Due in part to the characteristic customized fit of Cerrobend eSC, the positioning of the 
collimator on the patient surface is highly reproducible.  As such, patient setup errors (e.g., head 
rotation) could translate into beam angle inaccuracies with respect to the aperture.  For example, 
if an aperture has a perpendicular or negative (divergent) bevel angle, deviation from the 
prescribed beam angle (with respect to the patient) can potentially cause a portion of the incident 
beam to be scattered by the proximal (upstream) surface of the skin collimator aperture edge, 
creating an increase in dose near the surface and a distal cold region, or “shadow,” in a portion of 
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the treatment field (Lax and Brahme 1980).  Consequently, a positive bevel angle is preferred to 
prevent a setup error from resulting in a “shadow” being cast over a portion of the treatment area 
(Figure 2.5). 
 
Figure 2.4:  Schematic diagram depicting the conventions used to describe the aperture bevel 
angles (ϴB°) in this study.  A positive bevel angle may also be referred to as “convergent” or as 
being “beveled out.”  Likewise, a negative bevel may be described as “divergent” or “beveled 
in.”  Also visible in the figure is the convention used to describe gantry rotation (ϴG°); the 
downward-pointing arrows are representative of the beam central axis and indicate the beam 
direction. 
In the present study, three patient-like skin collimators were fabricated using the 
following technique.  To fabricate a Cerrobend skin collimator, a plaster stone positive of the 
region of the patient containing the treatment field was created.  The treatment field was then 
directly drawn on the patient-surrogate by the physician.  A thin line was etched into the stone 
that follows the physician-defined field shape.  A wall (of Styrofoam, used for Cerrobend 
shielding block construction, or a clay-like modeling compound) was then built around the stone 
to dam the molten Cerrobend that was poured onto the bust.  When necessary, modeling 
compound was used to create small spaces between the skin collimator and any surface 
structures that may hinder or prevent the separation of the eSC from the stone bust.  
After the Cerrobend was poured and cooled, the stone bust was carefully pried away from 
the hardened Cerrobend.  The appropriate thickness of the skin collimator, per Equation 2.2, was 








Figure 2.5: eSC “shadow”—Displayed (approximately to scale) are isodose plots for a 6 MeV 
electron beam with the gantry angle (ϴG°) offset to -5° using Cerrobend eSC with (a) a +10° 
bevel angle, (b) a 0° bevel angle, and (c) a  -10° bevel angle.  The distal surface of the eSC was 
positioned 50 mm OAX, and the beam edge defined by the eSC is illustrated with a dashed red 
line.   
 
For (a) a +10° bevel angle, the geometric distance of the beam edge from 50 mm OAX at the 
surface ([A]; green line, arrows) was zero.  The penumbral width (P90-10) at a depth of 10 mm 
([B]; orange arrows) was 8.2 mm.  The distance of the projected beam edge at the depth of 
maximum dose (dmax = 14 mm) from 50 mm OAX ([C]; black arrows) was 0.4 mm.  The positive 
bevel provides a more forgiving margin of error in the presence of rotational setup error.  If a 
“shadow” is cast by the eSC, penumbral sharpness is diminished, the homogeneity of dose is 
reduced, and the treatment field area is reduced causing an unexpected (and potentially 




Figure 2.5 (continued):  eSC “shadow”—Displayed (approximately to scale) are isodose plots for 
a 6 MeV electron beam with the gantry angle (ϴG°) offset to -5° using Cerrobend eSC with (a) a 
+10° bevel angle, (b) a 0° bevel angle, and (c) a  -10° bevel angle.  The distal surface of the eSC 
was positioned 50 mm OAX, and the beam edge defined by the eSC is illustrated with a dashed 





For (b) a 0° bevel angle, the geometric distance of the beam edge from 50 mm OAX at the 
surface ([A]; green line, arrows) was 0.7 mm.  The penumbral width (P90-10) at a depth of 10 mm 
([B]; orange arrows) was 10. 8 mm.  The distance of the projected beam edge at the depth of 
maximum dose (dmax = 14 mm) from 50 mm OAX ([C]; black arrows) was 1.3 mm.  The 
proximal surface of the eSC slightly reduced the field size at the surface, which resulted in a 
small shift of the treatment field ([A] and [C]) and an increase in penumbral width ([B]) as 






Figure 2.5 (continued):  eSC “shadow”—Displayed (approximately to scale) are isodose plots for 
a 6 MeV electron beam with the gantry angle (ϴG°) offset to -5° using Cerrobend eSC with (a) a 
+10° bevel angle, (b) a 0° bevel angle, and (c) a  -10° bevel angle.  The distal surface of the eSC 
was positioned 50 mm OAX, and the beam edge defined by the eSC is illustrated with a dashed 






For (c) a -10° bevel angle, the geometric distance of the beam edge from 50 mm OAX at the 
surface ([A]; green line, arrows) was 3.3 mm.  The penumbral width (P90-10) at a depth of 10 mm 
([B]; orange arrows) was 10.1 mm.  The distance of the projected beam edge at the depth of 
maximum dose (dmax = 14 mm) from 50 mm OAX ([C]; black arrows) was 3.8 mm.  The 
proximal surface of the eSC substantially reduced the field size at the surface, which resulted in a 
significant shift of the treatment field ([A] and [C]) and an increase in penumbral width ([B]) as 





2.1.3  Machined (Brass) Skin Collimators 
To circumvent the previously established difficulties associated with skin collimation 
fabrication, a commercial device manufacturer (.decimal, Inc.) is developing the capability to 
provide custom brass skin collimators to clinics unable or averse to create eSC in-house.  Brass 
is an alloy of Copper and Zinc, and the proportions of each can be varied to exploit various 
properties (such as hardness and density) of the component elements.  The density of the brass 
used by the manufacturer was reported to be 8.498 g/cm
3
.  Thickness calculations for skin 
collimation constructed from this material were calculated according to 
          (   ),                                                          (2.3) 
as (ρPb / ρbrass) = (11.3 / 8.5) ≈ 1.3.  Several properties contributed to the selection of brass as the 
material to be used for the manufacturer’s eSC.  Required thickness of the eSC and production of 
bremsstrahlung dose are minimized by the high density and intermediate atomic number, 
respectively, of brass.  Additionally, brass is durable and is an excellent machining material 
(Hogstrom et al. 1985).  The absorbed dose due to electrons scattered through a collimator edge 
is inversely proportional to the density of the collimating material and only has a weak 
dependence on energy and atomic number (Lax and Brahme 1980).  Thus, due to the lower 
density of Cerrobend and brass, relative to that of lead, a small increase in dose near the eSC 
aperture edges was expected due to scattered electrons. 
2.1.3.1     Computer-Aided Design of Machined Skin Collimation 
The brass eSC machined by the manufacturer was designed within a commercial 
Treatment Planning System (TPS) (Philips Pinnacle
3
, Philips Electronics North America 
Corporation, Andover, MA) by first scanning the patient—or phantom in our case—on a kVCT 
scanner.  A large bore, multi-slice CT scanner (GE LightSpeed, General Electric Medical 
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Systems, Fairfield, CT) was used in this study.  The phantom image sets were acquired using 
common clinical settings for kVCT scans: the tube current and tube potential were 400 mA and 
120 kVp, respectively.  The phantoms were imaged using the helical scanning technique with a 
pitch of 0.938 and a slice thickness of 2.5 mm.  The central sagittal plane of the phantoms was 
aligned with the sagittal laser plane of the kVCT scanner.  After importing the image set into the 
TPS, the brass eSC was designed using the following procedure described in the captions of 
Figures 2.6-2.11. 
2.1.3.2   Manufacturing of Machined Skin Collimation and Wax Replica 
 Once designed within the TPS, DICOM files were exported from the TPS and imported 
into the manufacturer’s (.decimal, Inc.) software via file-transfer protocol.  The manufacturer’s 
software converted the planned eSC from its DICOM structure (i.e., a set of slice contours) into a 
pair of surface meshes.  This pair of surface meshes represented the proximal and distal surfaces 
of the eSC with respect to the electron beam orientation.  The conversion process involves ray-
tracing along the beam’s central-axis to determine the proximal and distal intersections with the 
DICOM eSC structure.  These surfaces are used to generate the pathways to be taken by the 
milling tool during the machining process. 
 The skin collimator was milled from a larger block of brass.  Each of the eSC surfaces 
(proximal and distal) was milled separately such that the brass must be flipped between the 
milling routines.  The manufacturer also milled a wax replica of the eSC to be used for kVCT 
quality assurance tests.  The manufacturer’s quality assurance procedure involved automated 





Figure 2.6:  Design procedure within the TPS, step one—Once imported into the TPS, regions of 
interests were contoured on the data sets, including critical organs (e.g., lungs, spine, eyes), the 
Planning Target Volume (PTV), and the external patient surface.  The PTV for this nose 
simulation is depicted by the blue shaded region.  The three views shown here (as well as in 
Figures 2.7-2.11) are the mid-transverse CT plane (upper); mid-sagittal CT plane (lower-left); 






Figure 2.7  Design procedure within the TPS, step two—An electron beam was then added at an 
appropriate beam energy, gantry angle, electron cone size, and collimator angle.  The beam 
energy was selected such that the distal surface of the PTV is encompassed by R90, the depth 
reached by 90% of the given dose.  While R90 should exceed the maximum depth of the PTV, the 
nominal beam energy was selected with consideration for possible critical structures distal to the 
PTV.  The beam to be used in conjunction with the eSC was set to 105 cm source-to-surface 
distance (SSD), as is common practice, to prevent any possible collision between the patient and 
an electron cone.  After a beam was created, an auto-surround electron block was added to 
collimate the beam to follow the PTV edge.  In the present case, the green lines show the edges 
of a 15×15 cm
2





Figure 2.8:  Design procedure within the TPS, step three—The Pinnacle
3
 TPS allows for the 
creation of an “auto-bolus,” which is a constant-thickness layer of (typically water-equivalent) 
material that can be placed atop the patient surface.  The thickness of the auto-bolus was dictated 
according to the required thickness of brass calculated from Equation 2.3.  The lateral extent of 
the auto-bolus was extended ≥ 3cm around the PTV.  When deciding the lateral extent of the 
auto-bolus, which eventually became the eSC contour, consideration for the 15×15 cm
2
 electron 
cone size was taken into account.  The auto-bolus was conservatively extended laterally outside 
the chosen electron cone size by 1-2 cm.  The auto-bolus was then converted into an ROI.  To 
accomplish this, the plan was saved and exited, and the “bolus.roi” and “plan.roi” files for this 
particular patient and plan were located and opened as text files.  Within the “bolus.roi” file, the 
text was copied from the beginning of the header reading “Beginning of Bolus ROI…” to the end 
of the file.  This copied text was then pasted to the end of the “plan.roi” file and saved.  After re-





Figure 2.9:  Design procedure within the TPS, step four—After enabling the beam visualization 
option, a contour was made to conform to the edge of the beam.  This resulted in a trapezoidal 
contour on each slice containing the visualized beam edge that had been collimated down by the 
auto-surround electron block.  We defined the aperture bevel angle to follow the beam 
divergence because assuming the absence of setup error, the ideal angle for the aperture bevel 
will match the angle of the beam fan-line at each specific lateral extent from central axis (CAX) 





Figure 2.10:  Design procedure within the TPS, step five—The final step in forming the contour 
of the eSC was to subtract the contour of the field edge (upstream from the phantom surface) 
from the auto-bolus contour to create the field-defining aperture.  The resulting ROI’s density 
was assigned at  8.498 g/cm
3
, i.e., the density of the machined brass eSC.  The eSC ROI was 
inspected for appropriate thickness and coverage then designated as the contour of the desired 





Figure 2.11:  Design procedure within the TPS, step six—The ROIs and plan were exported from 
the TPS and uploaded into the manufacturer’s commercial software (p.d v4.2, .decimal, Inc., 
Sanford, FL).  p.d v4.2 is .decimal, Inc.’s proprietary software used to convert an ROI’s spatial 
information into a format compatible with CNC machinery.  Once in the manufacturer’s 
software, the appropriate ROI was selected, optimized, and submitted to the manufacturer for 
production.  The optimization process performs coordinate system transformations necessary to 






Chapter 3:  Specific Aim 1—Dosimetric Influence of eSC Bevel Angle 
3.1 Methods and Materials 
3.1.1  Variation of the Angle of the Aperture Edge 
The introduction of collimation to an electron beam is known to degrade and perturb the 
homogeneity of a dose distribution near the field edge due to electrons scattered from the 
collimator edge (Lax and Brahme 1980).  The present study investigated the significance of the 
collimator edge angle (ϴB).   
 A collection of fifteen Cerrobend skin collimators was used to establish a range of 
aperture edge angles (with respect to the beam CAX) that would be considered typical of clinical 
applications (Figure 3.1).  These collimators had been previously used in our clinic for the 
treatment of various head and neck lesions.  On each collimator, the aperture edge angle, or 
bevel angle, was measured at four locations—the superior, inferior, left, and right edges.  A 
stainless steel protractor equipped with a 15.24 cm locking arm was used to measure these angles 
(Figure 3.2).  For these measurements, the arm of the protractor was positioned along the bevel 
surface, and the face of the protractor was positioned proximal to the eSC aperture and 
approximately perpendicular to the beam direction, such that the bevel angles were measured 
with respect to the CAX of the electron beam.  Another set of measurements was taken from this 
collection of skin collimators to characterize the thickness of Cerrobend collimators. 
3.1.2  Variation of Gantry Angle from Nominal Delivery Angle 
 As previously stated, the aperture angle is often beveled “out” (positive bevel angle) in 
order to account for rotational setup error, or to avoid casting a “shadow” across a portion of the 
field (Figure 2.5).  In some situations, precise patient positioning or accurate skin collimator 
placement, can be difficult to achieve with consistency.  Typically, markings are made on the 
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patient surface to facilitate proper positioning, as patient positioning errors can cause significant 
changes to the dose distribution.  To simulate an angular setup error in which the patient is 
positioned with a minor rotational error, the gantry angle was systematically varied.  For the 
investigation of the dosimetric effects of the bevel angles, film measurements were collected for 
beveled collimators at relative gantry angles (ϴB) of 0°, ±3°, and ±5°, where a 0° angle is 
considered to be the nominal gantry position in which the beam is aimed toward the ground.  In 
this study, a positive gantry angle denotes a clockwise gantry rotation as shown in Figure 3.3.  In 
the analysis of this data, each field was halved along CAX , and the right half was mirrored (left-
to-right), i.e., for the analysis, the beveled eSC was always located on the left, and the CAX was 
to the right.  Thus, when the left half had a +ϴG°, the right half had a -ϴG°. 
 
 
Figure 3.1:  Collection of patient Cerrobend skin collimators used to determine common clinical 
attributes.  The general treatment sites are as follows:  whole nose (1-4), inner canthus (5), partial 




Figure 3.2:  In the image at left, approximate locations of protractor measurements are marked 
with yellow lines around the aperture edge: superior, inferior, right and left.  The protractor used 
is pictured on the right.   
 
 
Figure 3.3:  The gantry angle is referenced in this study with respect to the nominal gantry 
position (i.e., with the treatment head directly above the couch and the beam directed straight 
downward).  We refer to this nominal position as a relative gantry angle (Grel) of 0°.  The yellow 
arrow represents the nominal beam direction, while the green and red arrows indicate the 
direction of positive and negative rotations, respectively.  The curved arrows represent the 





3.1.3  Effects of Beveled Collimator Edges—Experimental Setup 
 To assess the dosimetric impact of the bevel angle, blocks were fabricated of Cerrobend 
with one edge tapered to 0° and 10° (see Figure 3.4).  These angles were chosen based on the 
previously established range of aperture edge angles taken from manual measurements of the 
fifteen Cerrobend skin collimators and considered typical of clinical applications.  To simulate 
the anticipated margin of error in patient set-up and physician adjustment of gantry angle, the 
gantry angle was varied at 0°, 3°, and 5°. To satisfy requirements of Specific Aim 1, we 
surveyed certain aspects of the current standard of care at our institution for the use of eSC with 
electron beam therapy.  We were primarily interested in angle of the aperture edge, or bevel 
angle.  Dimensional measurements were taken of fifteen Cerrobend eSCs that were previously 
used for treatments in our clinic.  A summary of that survey, presented below in Table 3.1, 
showed the mean angle (±σ) was +30.4° (±9.0°).  While eSC thickness is determined by the 
nominal beam energy and the collimating material used, the thickness measurements in Table 3.1 
were a reasonable indicator of the typical eSC thickness, as well as the wide interval of possible 
thicknesses.   
 A preliminary investigation was performed using eSCs with bevel angles of +30°, +20°, 
+10°, 0°, -10°, -20°, and -30° and a 12 MeV electron beam.  We observed that the eSC with 
bevel angles of +20° and +30° both resulted in a noticeable increase in dose at shallow depths 
near and behind the beveled eSC edge (Figure 3.5).  Presumably, this increase in surface dose 
was due to an increase in the number of electrons scattered from the eSC edge, as well as 
electrons penetrating the thinner portion of the bevel and depositing their remaining energy near 
the surface of the phantom.  Despite an average bevel angle of +30.4° in our clinical sample and 
based on these preliminary data on the effects of bevel angle variations at 12 MeV, the bevel 
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angle interval from -10° to +10° using a 6 MeV beam was selected for the focus of this 
investigation.  With future machined eSC and with the optimal angle presumably being parallel 
to the beam divergence, a bevel angle greater than ±10° seems suboptimal.  
 Dosimetric measurements were made using radiochromic film (RCF) in slabs of water-
substitute plastic.  To account for any non-uniformity in the slabs that might yield discrepancies 
in dose distribution, the slabs were positioned identically for each measurement.  The slabs were 
compressed by bar clamps to minimize the effect of any air gaps between the film and the slab 
(Figure 3.6b).  Three film measurements (n = 3) were taken for each setup.  Measurements were 
taken at 100 cm SSD on a linear accelerator (Clinac 21EX 4-10, Varian Medical Systems, Inc., 
Palo Alto, CA) using an electron beam energy of 6 MeV.  A 15×15 cm
2
 applicator collimated the 
beam. The beveled skin collimator was placed on the surface of the phantom, further collimating 
the field width to 10 cm.  The RCF was exposed en face (edge-on) to approximately 400 cGy at 
dmax.  The ranges of bevel and gantry angle variations selected for this study are listed in Table 
3.2.  The specific setups used to measure the effects of bevel and gantry angle variations are 
listed in Table 3.3.  
Table 3.1:  Results from a survey of aperture bevel angles and thicknesses measured from fifteen 

















Table 3.2:  The field setups used to measure the selected ranges of bevel and gantry angle 
variations. The cells of the measured fields are marked with a ‘’ on a yellow background.  
Details of how this was accomplished using 6 setups is shown in Table 3.3. 
 
Table 3.3:  The specific field setups used to measure the effects of bevel and gantry angle 
variations for Ep,0 = 6 MeV. 
 
 
Figure 3.4:  Example setup of the phantom apparatus used for bevel angle measurements.  The 
two beveled collimators pictured are the +30°collimator (on left) and the +20°collimator (on 
right).  Each are placed 5 cm from central axis atop four-5 cm slabs of solid water.  This image 
was taken during our preliminary investigation using a 12 MeV beam and including bevel angles 
up to 30°. 
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Figure 3.5:  Example isodose distributions of 12 MeV preliminary bevel data—0° (upper-left) 
and +10° (upper-right), +20° (lower-left), and +30° (lower-right) bevels with a 0° gantry angle.  
The 10% (violet) and 20% (blue) isodose curves show the penetration of the incident electrons 
through the thinner portion of the eSC bevel, and an increase in dose from electrons scattered 
from the eSC aperture edge can be seen in the 90% isodose curve as it is drawn more toward the 
surface for the +30° bevel. 
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3.1.4  Effects of Beveled Collimator Edges—Film Dosimetry 
 RCF (Gafchromic EBT2, International Specialty Products, Wayne, NJ) (Lot # 
F06110901, A09171003, and A12041005A) was used to quantify the effects of beveled 
collimator edges.  Each 20.3×25.4 cm
2
 sheet of film was halved into two 20.3×12.7 cm
2
 sheets, 
one of which was then placed between the two inner slabs of water-substitute plastic, with the 
edge aligned to the proximal surface.  Dutreix and Dutreix (1969) reported for radiographic film 
[1] that if the film edge is not precisely aligned to a phantom surface, en face film measurements 
with the film protruding outside (inside) the phantom surface can underestimate (overestimate) 
dose near the surface (depth < 2 cm) by as much as 10% for a 0.1 cm error (Figure 3.6a) and [2] 
that if any air gap (0.25-0.75 mm) exists between the film and phantom, the film measurements 
underestimate the dose at the surface before sharply increasing to overestimate the dose by 10%-
30% (Figure 3.6b).  The former was addressed by placing the factory-cut edge at the phantom 
surface per the procedure described in the next paragraph.  The latter was addressed by using two 
bar clamps to compress the phantom enveloping the RCF.  However, even making these 
changes, Robertson (2010) noted an unexplained surface effect, wherein the RCF measurements 
consistently underestimated the dose by as much as 3-4% at shallow depths  (< 2 cm) at higher 
electron energies (16-20 MeV). 
 Efforts were made to ensure appropriate and consistent alignment of the film.  Alignment 
marks were made on the inner surface of the phantom to center the film laterally and position the 
film edge at the surface.  As the phantom edges were slightly beveled (45° bevel, 1 mm deep), 
the film was placed at the bevel corner to ensure that the film did not extend into the air, and the 
distal film edge was taped to the inner surface of the phantom to prevent the film from shifting 
during phantom construction.  This resulted in the film edge being 1 mm below the bulk of the 
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phantom surface with a 45° bevel dropping to the film.  Such geometry should produce a slight 
increase in the film reading near the surface and underestimate R50 by 1 mm.   
 Excluding calibration exposures, each film was exposed to approximately 400 cGy 
maximum dose (400 MU/field).  The delivered dose was determined by the machine output, 
which was checked immediately before each measurement session.  We followed the protocol set 
forth by AAPM Task Group 51 (Almond et al. 1999) for the beam dose output checks.  Per 
AAPM Task Group 142 (Klein et al. 2009), water-substitute plastic (Plastic Water, Elimpex-
Medizintechnik, Moedling, Austria) was used in lieu of a liquid water phantom.  A 0.6 cm
3
 
thimble ionization chamber (PTW Farmer, Type 30006, PTW, Hicksville, NY) was positioned at 
100 cm SSD inside a slab of water-substitute plastic at energy-dependent reference depths (dref) 
(dref = 1.4 cm for 6 MeV; dref = 4.1 cm for 16 MeV) with 10 cm of water-substitute plastic placed 
downstream for backscatter.  The chamber was positioned along the CAX of a 10×10 cm
2
 field.  
The reference depths were determined by the water-equivalent depth based on the relative 
stopping power of the water-substitute plastic, as recommended by AAPM Task Group 25 (Khan 
et al. 1991).  An aneroid barometer was used to measure the local atmospheric pressure, and the 
temperature was measured inside the Plastic Water prior to the beam output measurements; these 
measurements were used to make necessary temperature and pressure corrections to the 
ionization chamber readings.  The results of these output measurements were used primarily to 
accurately normalize the film data to the given dose.   
 For conversion from optical density to absorbed dose, a calibration curve was measured 
for each beam energy used for each batch of film.  Each calibration curve was established with 
12 measurements following the methodology set forth by Robertson (2010).  A single sheet of 
RCF was divided into 6.35×6.35 cm
2
 squares (12).  Each square was exposed to a different, 
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known dose.  To maintain orientation, the bottom left corner of each square was numbered prior 
to dividing the film sheet into the squares.  The film was placed at an equivalent depth of 
maximum dose (dmax) with respect to the beam energy (Ep,0) in Plastic Water slabs with 10 cm of 
backscatter.  For the beam energies used in this study, 6 and 16 MeV, the dmax values used were 
1.4 and 3.3 cm, respectively.  The surface of the Plastic Water was positioned at 100 cm SSD, 
and the beam was collimated with a 10×10 cm
2
 cone.  The 12 squares were irradiated, 
perpendicular to the beam direction and centered within the 10×10 cm
2
 field, to the following 
doses: 0, 60, 110, 170, 220, 280, 330, 390, 440, 490, 560, and 610 cGy.  The unexposed RCF 
square allowed determination of dose readings below 60 cGy.   
 All film measurements, including calibration squares, were digitized using a transmission 
type (white light-source) scanner (VIDAR DosimetryPRO Advantage, SN: 320419, Vidar 
Systems Corporation, Hendon, VA).  The RCF squares were scanned with the aid of a template, 
as shown in Figure 2.20 in Sutton (2011), to carry them through the scanner on a reproducible 
path.  Each scan of the loaded template digitized 4 RCF calibration squares.  We followed the 
recommended digitizing process from the manufacturer.  Once digitized, dose was correlated to 
the average pixel value of a 2×2 cm
2
 region in the center of each film image.  A piecewise 
polynomial fitting function was used within commercial software (RIT113 v5.2, Radiological 
Imaging Technology, Inc., Colorado Springs, CO) to produce a calibration curve from the 12 
data points.  The resulting curve was used to convert the scanner values of the digitized RCF to 
dose (see Figure 3.7).  
 Film calibration, registration, and cropping were performed using commercial software 
(RIT113 v5.2, Radiological Imaging Technology, Inc., Colorado Springs, CO).  The films were 
digitally registered using a 5-point registration template created within the software 
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corresponding with a physical template.  Prior to scanning, the physical registration template was 
used to precisely mark each film.  The digitized film images were exported for analysis, 
including normalization, using in-house MATLAB software (The Mathworks, Nattick, MA).  
Each film data array was normalized to the given dose, adjusted for the beam output measured 
just prior to irradiation of the films. 
 (a)          (b)  
Figure 3.6:  Common errors seen in film dosimetry of high energy electrons related to imprecise 
experimental setup as demonstrated by Dutreix and Dutreix (1969).  Shown are (a) the effects of 
film edge misalignment and (b) effect of air gap between the film and the phantom for en face 
film measurements. 
 
Figure 3.7:  Measured RCF calibration dose points with a piecewise polynomial fit. 
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3.1.5 Comparison of Measured Dose Distributions 
3.1.5a  Therapeutic Dose Region 
Measured dose distributions were compared using several quantitative metrics.  Of 
particular interest was the 90% relative dose region, as prescriptions for electron therapy are 
defined such that the PTV should be encompassed by this isodose line.  To investigate this 
agreement, pixel values greater-than or equal-to 90% were gleaned from the normalized dose 
array and placed into a separate array.  This new array was then inspected and compared through 
several different methods.  With the pixel size of 0.5 mm, (1) the depth (R90) of the 90% dose 
region was determined, and (2) the pixel size was used to calculate the area encompassed by the 
90% isodose line within the film plane.  We hypothesized that the reduction of the area within 
the 90% relative dose region would be ≤ 5% and that any change in the depth of R90 on CAX 
would be ≤ 1 mm. 
Dose due to electrons scattered from the eSC edges will degrade the uniformity of the 
dose distribution (Lax and Brahme 1980).  The uniformity within the 90% dose region was 
examined to observe the changes in collimator-scatter seen with the different collimating 
materials and deviations in the collimator-edge construction. 
3.1.5b  Penumbral Width 
A deviation from a 0° bevel angle will affect the amount of scatter from the collimator 
edge.  Additionally, the beveled collimator edge will partially attenuate some electrons and 
create an increase in dose near the surface leading to a decrease in dose downstream.  As such, 
the sharpness of the penumbra will be diminished by the contributions of these actions (Lax and 
Brahme 1980).  To measure the penumbra widths, four rows of data, each at a different depth, 
were taken from the normalized dose array.  The chosen depths were dependent on the nominal 
beam energy.  The values in these rows were converted to off-axis ratios (OARs) by normalizing 
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each value to the value found at CAX.  The penumbral width (P80-20) at each depth was defined 
as the distance between the 80% and 20% OARs.  We hypothesized that any increase in 
penumbral width would be ≤ 2 mm. 
3.2 Results for Specific Aim 1 
 For comparison of the beveled eSCs, we were interested in [1] overall dosimetric 
agreement (Figures 3.8-3.10), [2] the impact of collimator scattered dose (Figures 3.8-3.11 and 
3.13), [3] penumbral width (Figure 3.12), and [4] the 90% relative dose region (Figures 3.11 and 
3.14-3.18).  Results of isodose curves for the conditions listed in Table 3.3 are plotted in Figures 
3.8-3.10.  The field setup with a bevel angle of 0° and a relative gantry angle of 0° was 
considered the prevailing standard of care and used as a standard of comparison.  A relative 
gantry angle, Grel, of 0° corresponds to a nominally positioned gantry (directly above the couch 
pointing downward); as such, a positive gantry rotation would be clockwise as viewed from the 
foot of the couch (Figure 3.3), while a negative gantry rotation denotes a counter-clockwise 
movement of the gantry.  For quantitative comparisons, Table 3.2 lists the area covered in the 
film plane by the 90% region for each field, while Table 3.3 lists the distal depth of the 90% 
relative dose for all measured combinations of bevel angle and relative gantry angle.  The 
penumbral widths, gleaned from the profiles plotted in Figure 3.12, are shown in Table 3.3.   
3.2.1 Collimator Scattered Dose 
Measured isodose plots for all gantry angles (0°, ±3°, and ±5°) at bevel angles of 0°, 
+10°, and -10° are plotted in Figures 3.8-3.10, respectively.  The eSC bevel angle had a 
relatively minor influence on the dose homogeneity of the measured distributions.  Electrons 
scattered from the eSC edge into the field created “hot spots” and “cold spots” within the 
treatment field.  A qualitative comparison of the dose uniformity within the 90% relative dose 
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region is shown in Figure 3.11, which contains nine subplots that have been arranged in rows 
according to bevel angle and columns by relative gantry angle.  Each of these subplots is a color-
mapped relative dose distribution in which the relative dose value of each pixel has been mapped 
to a particular color with respect to the color bar shown at the bottom of the Figure.   
Figure 3.12 contains nine subplots that have been arranged similarly to Figure 3.11.  Each 
of the subplots contains lateral profiles from each measured field taken at depths of 5, 10, 14, and 
18 mm.  The maximum value of each of these profiles is plotted in Figure 3.13, providing a more 
quantitative comparison of these fields.  As a quantitative comparison, the penumbral widths 
were measured at the four profile depths for each measured field (Table 3.4).   
Figure 3.13 is arranged into six subplots, and the data shown within these subplots is 
grouped by bevel angle (left column) with variation of gantry angle in each subplot and by 
gantry angle (right column) with variations of the bevel angle in each subplot. 
Figures 3.14-3.18 show the 90% relative dose area comparison plots.  By grouping the 
various data and plots, our intention is to identify characteristics or trends with respect to the 
variation in the eSC bevel angle and in the presence of simulated setup error (variations in the 
relative gantry angle).   
3.2.2  Penumbral Width 
 The penumbral widths (P80-20) are listed Table 3.4 from the profiles plotted in Figure 
3.12.  We defined the penumbral width as the lateral distance between the 80% and 20% relative 
dose points along each profile.  The penumbral width definitely increases with decreasing bevel 
angle (+10° → -10°) and depth, but less variation was seen with change of the gantry angle.  The 
difference in penumbral width was very small between the measured fields.  Upon comparing the 
penumbral widths of all the measured fields and all lateral profile depths, the largest difference 
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was 2 mm, for only one instance; all other differences were ≤ 1.5 mm.  This difference is not 
considered to be clinically significant. 
3.2.3 90% Dose Area 
 Figures 3.14-3.18 specifically address the coverage of the 90% dose area.  The +10° 
bevel increases the contribution of scattered electrons to the dose, but the distributions measured 
with the +10° beveled eSC were observed to be the least affected by variations in the gantry 
angle (±5°).  This is, perhaps, most clearly shown in the comparisons of the 90% relative dose 
areas (Figures 3.14-3.18) and in the calculated areas listed in Table 3.2.  For a nominal gantry 
angle, increasing the bevel angle from 0° to +10° resulted in a 16% increase in the 90% relative 
dose area.  Additionally, the lateral extent of the 90% isodose line was shown to be the most 
stable in the presence of gantry angle variations (±5°) for the +10° beveled eSC.  The -10° bevel 












Figure 3.8:  Isodose plots of the measured dosimetric data for the investigation into the 
dosimetric effects of eSC bevel angles.  Dosimetric measurements were obtained using 
radiochromic film with a 6 MeV electron beam.  Shown are measurements for a 0° bevel angle 
and (a) a 0° gantry angle, (b) a +3° gantry angle, (c) a +5° gantry angle, (d) a -3° gantry angle, 
and (e) a -5° gantry angle. 
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Figure 3.8 (continued):  Isodose plots of the measured dosimetric data for the investigation into 
the dosimetric effects of eSC bevel angles.  Dosimetric measurements were obtained using 
radiochromic film with a 6 MeV electron beam.  Shown are measurements for a 0° bevel angle 
and (a) a 0° gantry angle, (b) a +3° gantry angle, (c) a +5° gantry angle, (d) a -3° gantry angle, 









Figure 3.8 (continued):  Isodose plots of the measured dosimetric data for the investigation into 
the dosimetric effects of eSC bevel angles.  Dosimetric measurements were obtained using 
radiochromic film with a 6 MeV electron beam.  Shown are measurements for a 0° bevel angle 
and (a) a 0° gantry angle, (b) a +3° gantry angle, (c) a +5° gantry angle, (d) a -3° gantry angle, 
and (e) a -5° gantry angle. 
(e)  
(a)   
Figure 3.9:  Isodose plots of the measured dosimetric data for the investigation into the 
dosimetric effects of eSC bevel angles.  Dosimetric measurements were obtained using 
radiochromic film with a 6 MeV electron beam.  Shown are measurements for a +10° bevel 
angle and (a) a 0° gantry angle, (b) a +5° gantry angle, and (c) a -5° gantry angle. 
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Figure 3.9 (continued):  Isodose plots of the measured dosimetric data for the investigation into 
the dosimetric effects of eSC bevel angles.  Dosimetric measurements were obtained using 
radiochromic film with a 6 MeV electron beam.  Shown are measurements for a +10° bevel 
















Figure 3.10:  Isodose plots of the measured dosimetric data for the investigation into the 
dosimetric effects of eSC bevel angles.  Dosimetric measurements were obtained using 
radiochromic film with a 6 MeV electron beam.  Shown are measurements for a -10° bevel angle 




Figure 3.10 (continued):   Isodose plots of the measured dosimetric data for the investigation into 
the dosimetric effects of eSC bevel angles.  Dosimetric measurements were obtained using 
radiochromic film with a 6 MeV electron beam.  Shown are measurements for a -10° bevel angle 






Table 3.4:  90% relative dose area [mm
2
] for all measured combinations of bevel angle and 
relative gantry angle for 6 MeV beams.  A reduction of the area within the 90% relative dose 
region was expected to be ≤ 5%. 
 
  
-5 -3 0 +3 +5
+10 514.0 539.3 528.8
0 449.0 494.3 465.3 476.3 467.8
-10 441.5 415.8 421.0
+10 1.10 1.16 1.14
0 0.96 1.06 1.00 1.02 1.01
-10 0.95 0.89 0.90
90% Relative Dose Area [mm
2
]
Gantry Angle [°]Bevel Angle 
[°]




Figure 3.11:  Uniformity within 90% plotted from bevel angle dosimetric measurements.  Each 
of the three plot areas in the top row are dose distributions measured using an eSC with a bevel 
angle of +10°.  Similarly, the middle and bottom rows correspond to bevel angles of 0° and -10°, 
respectively.  The columnar grouping of the plot areas corresponds to the relative gantry angle in 
each; from the left column to the right column, the relative gantry angles were -5°, 0°, and +5°.  
The relative dose value for each pixel in each plot was mapped to a color with respect to the 




Table 3.5:  R90 depth on central axis for all measured combinations of bevel angle and relative 







Gantry Angle [°]Bevel 
Angle 
[°]
-5 -3 0 +3 +5
+10 18.0 18.0 18.0
0 18.0 18.0 18.0 18.0 18.0
-10 18.0 17.5 18.0
Depth of R90 on CAX [mm]






Figure 3.12:  Lateral profile plots plotted from bevel angle dosimetric measurements. The nine 
subplots are grouped in rows by bevel angle and columns by relative gantry angle.  The rows, 
from top to bottom, correspond to bevel angles of +10°, 0°, and -10°, respectively, while the 
columns, from left to right, correspond to relative gantry angles of -5°, 0°, and +5°.  Each subplot 
contains four lateral profiles taken at four depths (5, 10, 14, and 18 mm).  Each depth is 
represented by a different colored line: depth = 5 mm (magenta), 10 mm (blue), 14 mm (green), 














Figure 3.13:  Profile relative dose maxima plotted from bevel angle dosimetric measurements.  
At each profile depth, the maximum value was plotted for comparison to other measured fields.  
The subplots are arranged such that the bevel angle is held constant in the left column, and the 
relative gantry angle is held constant for those in the right column.  Shown by a red line and data 
points on each of the subplots is the field setup with a bevel angle of 0° and a relative gantry 
angle of 0°; this field was used as a standard of comparison. 
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Table 3.6:  Penumbral widths measured from data collected with variations in eSC bevel angle.  
Provided is a quantitative comparison of penumbral widths of the selected electron fields in our 
assessment of the dosimetric effects of variations in eSC bevel angle.  These penumbral widths 
were taken from the lateral profile data shown previously in Figure 3.12.  We defined the 
penumbral width as the lateral distance between the 80% and 20% relative dose points along 
each profile.  The difference in penumbral width was very small between the measured fields.  
Upon comparing the penumbral widths of all the measured fields and all lateral profile depths, 
the largest difference was 2 mm, and there was only one instance of this; all other differences 
were ≤ 1.5 mm. 
 
 
Figure 3.14:  Measured 90% relative dose area comparison.  The bevel angle was held constant 
at 0° and the gantry was varied at 0°, ±3°, and ±5° to demonstrate the possible effects of 
rotational setup error.  The region shaded in red is the 90% relative dose area for the field setup 






Gantry Angle  
[°]
dref = 5 mm dref = 10 mm dref = 14 mm dref = 18 mm
+10 +5 1.5 5.0 7.5 10.0
+10 0 1.5 4.0 7.0 9.0
+10 -5 1.5 3.5 6.5 9.5
0 +5 1.5 4.0 7.0 10.0
0 +3 1.0 4.0 7.0 9.5
0 0 1.5 4.0 7.5 10.0
0 -3 1.5 4.0 7.0 9.5
0 -5 2.0 4.0 7.0 10.0
-10 +5 2.0 4.5 8.0 10.5
-10 0 2.5 5.0 8.0 11.0




Figure 3.15:  Measured 90% relative dose area comparison of bevel angles.  Relative gantry 
angle was held constant at 0° for Cerrobend eSCs with bevel angles of 0°, +10°, and -10° to 
demonstrate the effects of bevel angle on the dosimetric distribution.  The region shaded in red is 
the 90% relative dose area for the field setup with a bevel angle of 0° and a relative gantry angle 
of 0° and was used as a standard of comparison. 
 
 
Figure 3.16:  Measured 90% relative dose area comparison of bevel angles.  Relative gantry 
angle was held constant at -5° for Cerrobend eSCs with bevel angles of 0°, +10°, and -10° to 
demonstrate the occlusive effects of the proximal surface of eSCs that have a bevel angle ≤ 0° in 
the presence of rotational setup error.  The region shaded in red is the 90% relative dose area for 
the field setup with a bevel angle of 0° and a relative gantry angle of 0° and was used as a 




Figure 3.17:  Measured 90% relative dose area comparison of bevel angles.  The bevel angle was 
held constant at +10° with the gantry varied at 0°, +5°, and -5° to demonstrate the stability of the 
90% relative dose region in the presence of rotational setup error and an eSC bevel angle of 
+10°.  The region shaded in red is the 90% relative dose area for the field setup with a bevel 
angle of 0° and a relative gantry angle of 0° and was used as a standard of comparison. 
 
 
Figure 3.18:  Measured 90% relative dose area comparison of bevel angles.  The bevel angle was 
held constant at -10° with the gantry varied at 0°, +5°, and -5° to demonstrate the negative 
impact on the 90% relative dose region in the presence of rotational setup error and an eSC bevel 
angle of -10°.  The region shaded in red is the 90% relative dose area for the field setup with a 
bevel angle of 0° and a relative gantry angle of 0° and was used as a standard of comparison. 
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Chapter 4:  Specific Aim 2—Dimensional Accuracy of the Machined eSC 
4.1 Methods and Materials 
4.1.1  Skin Collimation Evaluation Cycle 
Each of the eSCs used in this project underwent a series of dimensional and dosimetric 
tests to ensure agreement with the planned eSC.  For this study, three separate phantom cases 
were examined.  This chapter examines the dimensional accuracy. 
Using CT images of a phantom, eSC was designed using a commercial TPS (Philips 
Pinnacle
3
, Philips Electronics North America Corporation, Andover, MA) as described in 
Section 2.1.3.1.  Once designed as a Region of Interest (ROI), the file containing the surface 
coordinates of the eSC ROI with respect to the CT coordinate system was imported into p.d v4.2.  
Upon submission of this output file to the manufacturer, the eSC was machined and delivered to 
MBPCC.  For each submission, the manufacturer machined a brass eSC, as well as a wax replica 
of the eSC (Figure 4.5[b]) to be used for quality assurance testing.   
A kVCT image set of the wax replica was acquired using a kVCT (GE LightSpeed, 
General Electric Medical Systems, Fairfield, CT) scanner and fused with the planned ROI using 
the TPS to assess equivalence of the machined eSC to the planned eSC.  The fusions were 
performed primarily by manually matching the distal surface and aperture edge of the eSC image 
to that of the planned eSC contour.  The brass eSC was scanned using a TomoTherapy unit (Hi-
Art, TomoTherapy, Inc., Madison, WI) MVCT imaging system and fused to the kVCT TPS data 
set, similar to the procedure for the wax replica (Figure 4.1).  Any observable dimensional 




4.1.2  Cylindrical Phantom Case 
The first case was planned on a high-impact white opaque (HIWO) polystyrene (ρ = 




 cylindrical phantom.  With a diameter of 27 cm and a length of 37.4 cm, the 
cylindrical phantom was selected for use in this study for its simplistic shape and capacity to 
collect film dosimetry measurements (Figure 4.3)(Chi et al. 2005).  As described by Kavanaugh 
(2011), the phantom contains two cassettes, each with a central slot to fit a single bare film.  
With respect to the longitudinal axis of the phantom, one cassette was positioned in a transverse 
plane and one in the central sagittal plane.  Dose measurements are assessed in Chapter 5 
(Specific Aim 3).  
Dose was prescribed such that 90% of the given dose encompassed the distal surface of 
an arbitrary PTV.  For the cylindrical phantom irradiation, a hypothetical PTV was constructed 
that was roughly 5×7 cm
2
 and of irregular shape.  The PTV (not shown; exact shape not relevant) 
reached a depth of just over 4 cm requiring a 16 MeV beam.  Using a 1 cm margin, the irregular 
field size was approximately 7×9 cm
2
 (Figure 4.2).  The aperture size was relatively large (about 
9 cm along the sagittal axis) as compared to most skin collimation applications (cf. Figure 3.1), 
but this was an intentional deviation in an attempt to minimize the influence of collimator edge 
scatter at the central axis.  The three collimating materials (brass, Cerrobend, and lead) were each 
used to construct eSC for the cylindrical phantom case (see Figure 4.5—top row) using methods 
described in Chapter 2.   
                                                 
 
1
 The discrepancy in the density of the cylindrical phantom was due to differing values reported in previous studies 
that utilized this particular phantom.  Chi et al. (2005) reported the density to be 1.035 g/cm
3
, while Kavanaugh 
(2011) designated the density to be 1.054 g/cm
3
.  Possibly contributing to the discrepancy, Khan et al. (1991) 
include a table of information on the physical properties of non-water phantoms in which they list a density of 1.054 
g/cm
3
 for high-impact polystyrene (white).  Regardless, we do not expect this difference (< 2%) in the density of the 




Figure 4.1:  MVCT fusion of the anthropomorphic head phantom (case #2) eSC.  The yellow 
contour lines represent the contour of the wax eSC.  The upper images are coronal planes of the 
eSC anterior (left) and posterior (right) aperture edges from the MVCT image set.  The lower-left 
image is a sagittal plane along CAX, and the lower-right image is a transverse plane, also along 
CAX. 
 
Figure 4.2:  3D rendering of the BEV for the cylindrical phantom taken from the TPS.  The PTV 
is shown (in blue) in the center of this image.  The axes in the image represent the cardinal axes 
of the electron beam, and each of the tick-marks represents 1 cm at an SSD = 100 cm.  The PTV 





Figure 4.3:  The HIWO polystyrene cylindrical phantom (Kavanaugh 2011)—the schematic 
drawings show in (a) the central sagittal plane and (b) a transverse plane or end view of the 
phantom (Chi et al. 2005).  As shown in (c) the phantom has two cassettes oriented in sagittal 
and transverse planes.  These cassettes have been partially removed in the image to clearly 
indicate their positions. 
4.1.3  Anthropomorphic Head Phantom Cases – Case 1 (Nasolabial Fold)                          
 and Case 2 (Whole Nose) 
The second and third cases were planned on an anthropomorphic phantom (RANDO, The 
Phantom Laboratory, Salem, NY).  The phantom was constructed using a natural human skeleton 
encased by soft tissue-simulating material and includes air cavities found within the head and 
neck region.  The phantom consisted of 2.5 cm transverse slabs to allow for the insertion of film 
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sheets, but this phantom was not used for film dosimetry in the present study.  For this study, we 
used the head and neck portion of the phantom (approximately down to the clavicle).   
The head phantom cases and PTVs, shown in Figure 4.4, were meant to mimic realistic 
clinical setups that require the use of eSC.  The first head phantom case was based on the 
treatment of a tumor located in the nasolabial fold area, and the second case was modeled after a 
whole nose treatment field.  The three collimating materials (brass, Cerrobend, and lead) were 
each used to construct eSC for each of the two head phantom cases (Figure 4.5—middle and 
bottom rows).  The brass eSCs for these two cases underwent an identical dimensional 
evaluation cycle as performed for the cylindrical phantom case (i.e., no comparison of film 
dosimetry for the brass eSC versus the lead and Cerrobend eSCs).  Film measurements with the 
head phantom were not included in this study as en face film irradiation within an 
inhomogeneous phantom has proven to be inaccurate due to perturbations caused by bone and air 
in the phantom abutting the film (Shiu and Hogstrom 1991).  Hence, the purpose of Figure 4.5 is 
to allow a visual comparison of brass, lead, and Cerrobend eSCs for the three phantom cases. 
4.1.4  Comparison of Brass Machined Skin Collimation to Planned Skin              
Collimation— Dimensional Characteristics 
 
As previously discussed in Section 4.1.1, each milled skin collimator underwent three 
tests to assess agreement with the planned eSC.  First, the calculated volume of the planned eSC 
was compared to the volume of the milled eSC.  In both the kVCT and MVCT image sets, the 
machined eSC was contoured on each of the CT images.  To accomplish this, an auto-contour 
function was used within the TPS, where the maximum and minimum thresholds were set to 
4095 and 2000, respectively.  After establishing the dimensional limits of the machined eSC with 
the contours, the volume of the physical eSC was calculated for comparison to the volume of the 
planned eSC.  Volumetric comparisons were used in conjunction with CT fusions to verify 
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conformity to the plan.  Additionally, these quantitative comparisons were only performed after 
the CT fusions qualitatively verified the absence of any deviations from the plan that could 
potentially have a clinically significant impact on the dose distribution. 
 In addition to the CT fusions, physical dimensions of the brass collimators were also 
collected and compared to measurements of the planned collimator within the TPS, which were 
collected using the distance measuring tool.  The distance measuring tool in the TPS calculated 
distances based on the CT coordinate system.  Per our criteria, the physical dimensions were not 
expected to deviate from the design by more than 2 mm.  The comparison of these dimensions, 
along with the volumetric comparisons, provided a quantitative comparison of the machined vs. 
planned dimensions.   
Three geometric quantities were assessed:  [1] eSC thickness, [2] distance between the 
distal eSC surface and the skin (phantom surface), and [3] distance between planned and actual 
aperture edge.  Measured eSC thickness was compared to the planned eSC thickness.  The fit of 
the manufactured collimator to the irregular surface of the head phantom was qualitatively 
evaluated through (a) visual inspection when placed on the phantom, and (b) the assessment of 
the surface conformity within the CT fusions.  The location of the aperture edge was compared 
with the planned edge.  
4.2 Results for Specific Aim 2 
4.2.1  Dimensional Accuracy of Machined eSC Devices 
 The primary purpose of Specific Aim 2 was to ensure that, upon delivery, the physical 
shape of the brass eSC matched the digital design specifications.  We performed several 
dimensional checks to confirm this, which included kVCT fusions of the wax surrogate eSC and 
MVCT fusions of the brass eSC to the planned region of interest, as well as physical 
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measurements of the dimensions of the eSC to be compared with dimensional distances 
determined using measuring tools in the treatment planning system.  Of particular interest in this 
study was [1] the accuracy of the thickness of the machined eSC, [2] the accuracy with which the 
distal surface of the machined eSC conformed to the contour of the patient surface, and [3] the 
accuracy of the eSC aperture edge.   
 Results comparing the planned eSC contour with the wax eSC shape in the kVCT images 
are shown in the upper portions of Figures 4.6-4.8 for the cylindrical phantom, head phantom 
(case #1), and head phantom (case #2), respectively.  Results of the MVCT images with the brass 
eSC fused with the planning kVCT images are shown in the lower portions of Figures 4.6-4.8. 
 
Figure 4.4:  Anthropomorphic head phantom PTVs—case #1 can be seen in the upper images 
and case #2 in the lower images.  Seen in orange are the planned eSC contours, and the treatment 
volumes are pictured in blue.  The images on the left of each row are 3-D renderings of the 






Figure 4.5:  Cylindrical phantom eSC (top row) and the anthropomorphic head phantom case #1 
(middle row) and case #2 (bottom row) eSC—[a] brass, Cerrobend, and lead (left to right) and 




Figure 4.5 (continued):  Cylindrical phantom eSC (top row) and the anthropomorphic head 
phantom case #1 (middle row) and case #2 (bottom row) eSC—[a] brass, Cerrobend, and lead 





4.2.2  Thickness Comparisons of Machined eSC Devices 
 The thickness of eSC dictates the amount of dose transmitted through the collimator and 
contributes to other aspects of treatment such as scatter.  The thickness of the machined eSCs 
was verified with the kVCT and MVCT fusions and, more precisely, with physical 
measurements.  The volumes of the machined eSCs were calculated using the CT image sets and 
used as a secondary comparison of the accuracy of the thicknesses.  Table 4.1 compares the 
minimum and maximum brass eSC thickness with the planned thickness of 1 cm (which was 
mistakenly less than the recommended 1.2 cm for 16 MeV electrons) and provides a volumetric 
comparison of the planned eSC to the physical eSC, as determined by the kVCT and MVCT 
image sets, for each phantom case. 
4.2.3  Agreement of Machined eSC Distal Surfaces 
For the brass to fit the patient surface well, its milled distal surface should match the 
designed surface within 2 mm.  In the mid-transverse planes, excellent agreement (≤1 mm) is 
illustrated using the kVCT scans of the wax eSC surrogate.  In all cases there appears to be a 
small air gap (≤1 mm) that is caused by the eSC not perfectly fitting the phantom surface, but 
qualitatively, the eSC seemed to fit exceptionally well when inspected by hand.  Despite the 
coarse steps due to the 2.5 mm CT scan thicknesses, the distal surfaces of the eSCs were 
sufficiently smooth for patient comfort. 
The MVCT images, as expected, were not as clear as the kVCT of the wax eSC replica.  
Some smearing and streaking was observed in all cases, but with appropriate window and level 
settings (as specified for each case in the captions of Figures 4.6-4.8), the brass eSC could 
become resolved enough for fusion with the planned eSC contour.  For each case, the brass was 
59 
 
nearly identical to the wax eSC replica, i.e., the minor differences between the distal surfaces of 
the planned eSC and the MVCT image of the milled eSC were within 1 mm.  
4.2.4  Agreement of Machined eSC Aperture Edges 
The machined eSC aperture edges were designed to be parallel to the beam divergence in 
the transverse planes.  Due to limitations in the design process (e.g., contours can only be created 
or edited in the transverse plane), this could not be done in the superior-inferior direction.  The 
cylindrical phantom eSC and the head phantom case #2 have a negative bevel angle such that, 
contrary to the design, the edges appear to emanate from a virtual source only 20 cm (or less) 
above the patient as opposed to 105 cm, which is the location of the virtual source in the TPS 
(Figures 4.6 and 4.8).  This deviation from the planned eSC edge shows up to a 3 mm difference 
where the eSC abuts the phantom surface.  Contrastingly, the head phantom case #1 results show 
agreement with the planned aperture edge within 1.5 mm and do not show an incorrect slope on 
the edge.  While the reason for this inconsistency remains under investigation, the cause is likely 
an error in either the p.d software or the data input.  
4.2.5  Other Observations 
One remaining observation was that the outer edges of all three eSCs were milled at least 
5-10 mm short in the superior-inferior direction.  Although not likely clinically significant, this 
deviation from the design is currently under investigation. 
4.2.6  Summary of Specific Aim 2 Results 
Overall, good agreement was seen between the dimensions of the machined eSC and 
those of the planned eSC.  The following summarizes the observations of Specific Aim 2:  [1] a 
≤ 1.5 mm difference was seen in the thickness of the cylindrical phantom case (i.e., the eSC was 
planned to be slightly more thick than the machined eSC was fabricated); [2] the distal surface of 
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the eSC matched the shape of the phantom surface within 1 mm; and [3] in all three cases, the 
eSC was missing approximately 2.5-5.0 mm from the extreme superior and inferior edges (i.e., 
each eSC was approximately 5-10 mm shorter in the superior-inferior direction).  These were all 
considered to be minor deviations from the planned eSC design.  These differences were not 
expected to have any sort of significant dosimetric impact and, thus, were not considered to be 
clinically relevant. 
However, in all cases, the aperture was designed to be parallel to the beam divergence, 
but in the cylindrical phantom case and the second head phantom case (whole nose) the 
divergence was significantly overestimated in some areas (≤ 2.5 mm).  These differences are 
considered clinically relevant and should be corrected prior to clinical utilization. 
 
 
Table 4.1: Volumetric comparison of the planned eSC to the machined brass eSC.  These 
volumes are based on calculated volumes within the TPS.  The machined brass eSC volumes are 











Planned eSC Thickness 1 cm 1 cm 1.2 cm
Thickness Range of     
Machined Brass eSC
0.85 - 1.05 cm 0.90 - 1.10 cm 1.05 - 1.20 cm














    
    
Figure 4.6:   kVCT and MVCT fusion images of the cylindrical phantom case.  Shown are the 
kVCT images (upper) of the wax eSC replica, where the planned eSC shape is represented by the 
blue line.  This same contour is shown overlaying the MVCT images (lower) of the brass eSC.  
The images on the left are transverse slices through CAX, and the right images are sagittal slices, 
also through CAX.  For the kVCT of the wax eSC replica, the window and level values used 
were 1065 and 309, respectively.  For the MVCT of the brass eSC, the window and level values 
used were 3224 and 646, respectively.  The MVCT of the brass eSC for the cylindrical phantom 
matched the planned specifications fairly well, with two exceptions.  The brass eSC was shorter 
than the planned eSC in the superior-inferior direction approximately 5-10 mm (shown in the 
sagittal kVCT image, and the brass eSC had a negative bevel angle, also in the superior-inferior 
direction, which deviated from the planned eSC as seen in the sagittal slice image.  A manual 




    
    
Figure 4.7:  kVCT and MVCT fusion images of the head phantom (case #1).  Shown are the 
kVCT images (upper) of the wax eSC replica, where the planned eSC shape is represented by the 
blue line.  A contour of the planned eSC shape is also shown overlaying the MVCT images 
(lower) of the brass eSC.  The images on the left are transverse slices through CAX, and the right 
images are sagittal slices through the central-sagittal axis of the phantom, which was not parallel 
to the beam CAX as the beam had a gantry rotation of +40° (see Figure 4.4).  For the kVCT of 
the wax eSC replica, the window and level values used were 1012 and 462, respectively.  For the 
MVCT of the brass eSC, the window and level values used were 1401 and 2599, respectively.   
For this phantom case, CT images were collected without the use of the head phantom.  The blue 
contour in the images is the external contour of the head phantom.  The brass eSC for the first 
head phantom case corresponded well to the planned eSC.  The lone deviation was a shortened 
brass eSC in the superior-inferior direction.   Similar to the cylindrical phantom, this eSC was 
approximately 5-10 mm short of the full planned superior-inferior length (about 2.5-5.0 mm 
from each end).  
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Figure 4.8:  kVCT and MVCT fusion images of the head phantom (case #2).  Shown are the 
kVCT images (upper) of the wax eSC replica, where the planned eSC shape is represented by the 
blue line.  A contour of the planned eSC shape is also shown overlaying the MVCT images 
(lower) of the brass eSC.  The images on the left are transverse slices through CAX, and the right 
images are sagittal slices through the central-sagittal axis of the phantom, also through CAX.  
For the kVCT of the wax eSC replica, the window and level values used were 1013 and 462, 
respectively.  For the MVCT of the brass eSC, the window and level values used were 1401 and 
2599, respectively.  The brass eSC for the second head phantom case corresponded well to the 
planned eSC, but again, the brass eSC was approximately 5-10 mm short of the full planned 




Chapter 5:  Specific Aim 3—Dosimetric Equivalence of the Machined eSC 
5.1 Methods and Materials 
This chapter compares 2-D dose distributions measured in the mid-sagittal plane of the 
HIWO cylindrical phantom.  A 16 MeV electron beam irradiated an irregular field (≈ 7×9 cm2) 
formed by brass, Cerrobend, or lead eSC.  Measurements were taken with a 0° and +3° gantry tilt 
relative to central axis. 
5.1.1 Experimental Setup 
All film measurements performed using HIWO cylindrical phantom were acquired using 
RCF (Gafchromic EBT2, International Specialty Products, Wayne, NJ) (Lot # F06110901, 
A09171003, and A12041005A), exposed en face (“edge-on”) in the sagittal film cassette of the 
phantom [19 cm×25.4 cm (depth×width)].  Since the RCF dimensions were 20.3 cm×25.4 cm, 
the film was trimmed, using a single-sided razor, to align the film edge with the phantom surface 
prior to exposure. For each measurement condition, results of three films were averaged. 
For irradiation, the longitudinal axis of the cylindrical phantom was aligned with the axis 
of gantry rotation of the linear accelerator as shown in Figure 5.1.  The couch, gantry, and 
collimator rotation were all set to 0°.  For each eSC material (brass, Cerrobend, lead) (Figure 
4.5), three films were exposed.  Additionally, to simulate setup error, the beam angle was rotated 
+3° in the plane of the film, and the measurements were repeated for all three eSCs.  This was 
facilitated by rotating the couch and collimator to 90° and the gantry to +3°.  The portion of the 
cylindrical phantom containing the sagittal cassette was considered superior with respect to head-
first-supine orientation, and each eSC was oriented as such.  The nominal beam energy used for 
the cylindrical phantom case was 16 MeV, the SSD was 105 cm, and the beam was collimated by 
a 15×15 cm
2
 electron cone.  Each film was exposed to 400 MU, and the corresponding dose was 
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determined by acquiring output measurements, as described in Section 3.1.4, prior to film 
irradiation.  This value of given dose was used to normalize the measured film dose distributions. 
Digitization of the film measurements was performed following previously discussed 
methods (Section 3.1.4).  The registration methodology was identical to that used previously by 
investigators using the sagittal cassette of this phantom (Kavanaugh 2011).  A physical 5-point 
template was made to mark the films prior to scanning with the registration points placed at 
known distances from the origin in areas of little or no interest on the film.  The films were 
digitally registered using a 5-point registration template created within commercial software 
(RIT113 v5.2, Radiological Imaging Technology, Inc., Colorado Springs, CO) corresponding 
with the physical template.  Using this template within the commercial software, the digitized 
film images were spatially registered to an ASCII planar dose calculation with a pixel size of 
0.05 cm×0.05 cm.  Once the film was calibrated and registered within the commercial software, 
the digitized film images were exported for analysis, including normalization, using in-house 
MATLAB software. 
5.1.2 Data Analysis   
The measured distributions were from digitized RCF measurements (see Section 3.14).  
The dose arrays exported by the RIT software as .mat files were analyzed using in-house Matlab 
v7.5 software written specifically for this study.  The exported arrays had a 0.5 mm pixel 
spacing.  Each array was normalized to the given dose (independent of eSC), adjusted for the 
beam output measured just prior to irradiation of the films.  Surface artifacts, similar to those 
reported by Robertson (2010), were observed both on CAX and near the eSC edge.  Therefore, 
for all data points within 2 cm of the surface (z ≤ 2 cm), the following correction was applied to 
the en face film dose measurements collected using the cylindrical phantom: 
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) ,       (5.1) 
where %Dclin(0,z) is the clinical CAX depth dose measured in a water phantom, and %Dmeas(0,z) 
is the CAX depth dose measured in the cylindrical phantom.  For shallow depths (z ≤ 2 cm), this 
correction restored agreement of our measurements with the measured dose in a water phantom.  
Typical results for this process are illustrated in Figures 5.2 and 5.3.  Since this effect was 
significantly diminished at lower energies (also observed by Robertson (2010)), the correction 
was not necessary for previously discussed (see Section 3.1.4) film dose measurements in this 
study at 6 MeV. 
   
Figure 5.1:  Cylindrical phantom experimental setup with Cerrobend eSC, pictured from the foot 
of the couch.  The phantom was extended further from the measurement SSD of 105 cm to allow 
the view (photo) of the eSC placement.  This particular image shows the Cerrobend eSC on the 
phantom.  The couch, gantry, and collimator rotation were all set to 0°.  For variation of the 
gantry from the nominal delivery angle, the couch and collimator were rotated to 90°, and the 
gantry was set to +3°; these adjustments allowed for a +3° gantry rotation within the film plane 
(central sagittal plane).  The proximal edge of the film plane is approximated in the right image 
by a line drawn along the longitudinal surface of the phantom. 
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5.1.3  Comparison of Measured Dose Distributions 
We compared 2-dimensional distributions of measured relative dose to evaluate 
dosimetric equivalence of the machined brass eSC with the current standard of care (lead eSC 
and Cerrobend eSC).  Measured dose distributions were compared using several quantitative 
metrics as previously described in Section 3.1.5.  Dose distribution agreement was investigated 
in order to validate the dosimetric equivalence of each collimating material.   
5.1.4  Leakage 
Collimator leakage was assessed to ensure that each collimating material demonstrated 
sufficient shielding properties to be used clinically.  This was only investigated for the 
cylindrical phantom case.  For this assessment, off-axis dose profiles were plotted at depths of 
0.5, 1.0, 2.0, and 3.0 cm with data 3 cm outside the field edge.  Also, in the normalized dose 
array, the depth-dose profiles, averaged over the data in the columns between 6.5 and 7.0 cm 
distance off-axis, were determined and plotted.  These depth-dose plots fell approximately 2 cm 
lateral to the eSC aperture edge. 
5.2 Results for Specific Aim 3 
For comparison of the three eSCs of different collimating materials (brass, Cerrobend, 
and lead), we were interested in [1] overall dosimetric agreement (Figures 5.4-5.5), [2] the 
impact of collimator scattered dose (Figures 5.4-5.6), [3] field width and the 90% relative dose 
region (Figures 5.6, 5.7, 5.9, and 5.10), [4] penumbral width (Figure 5.8), and [5] radiation 
leakage (Figures 5.8 and 5.11).  The lead eSC was considered to be the prevailing standard of 
care.  The penumbral widths are listed Table 5.2, and the profiles from which they were gleaned 
are plotted in Figure 5.8.  The leakage seen with the brass eSC measurements was due to errors 
made in the planning process and is addressed in section 5.2.4.  Otherwise, all three of the eSCs 
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for the cylindrical phantom case showed very good dosimetric agreement.  Slight variations were 
seen in the width of the eSC aperture between the three (approximately 2-3 mm), but since the 
Cerrobend eSC and lead eSC were fabricated by hand according to the current standard of care at 
our institution, a variation of a few millimeters was likely within the expected uncertainty. 
5.2.1  Collimator Scattered Dose 
Measured isodose plots for the brass, Cerrobend, and lead eSCs for 0° and +3° gantry 
angles are plotted in Figures 5.4 and 5.5, respectively.  In all cases a lobe of increased dose 
(>100%) due to collimator scatter is observed.  At 0° the increased dose is slightly greater in the 
negative direction, which is due to the collimating edge parallel to gantry axis being closer to the 
film measurement plane at the inferior (negative) field edge, cf. Figures 4.2 and 5.1.  For brass 
eSC the maximum doses at dref = 10 mm are approximately 107%(-) and 105%(+); for Cerrobend 
eSC approximately 104%(-) and 100%(+); and for lead eSC approximately 105%(-) and 
103%(+).  Figure 5.6, a color-wash dose plot of dose values 90-110%, better illustrates a 
qualitative comparison of the increased dose due to collimator scatter.  Small differences can be 
seen in the collimator-edge scatter, attributed to the different properties of the collimating 
materials as well as the different bevel angles of the eSCs (negative bevel angle, slightly greater 
than the angle of the beam divergence; approximately +20°; and approximately parallel to CAX 
for the brass, Cerrobend, and lead, respectively).  The brass eSC shows increased scatter dose 
compared to lead, which is slightly greater than that for Cerrobend.  Results for a +3° gantry 
angle were similar, perhaps, showing slightly less dose (1-2%) on both sides.  The features of 
these comparisons can be more quantitatively appreciated using the off-axis dose profile plots in 







Figure 5.2:  Percent depth dose plots before (left) and after (right) the correction of the surface 







Figure 5.3:  Plots of the uniformity within 90% relative dose region before (upper) and after 
(lower) the correction of the surface effect.  
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5.2.2  Field Width and 90% Dose Area 
Figure 5.9 overlays isodose curves of 20%, 50%, 80%, and 90% for the brass, Cerrobend, 
and lead eSCs.  These curves have essentially identical shapes (≤ 1 mm) with the exception of 
the lead isodose curves being shifted -1 mm in the negative half plane and the Cerrobend isodose 
curves being shifted +1.5 mm in the positive half plane.  These shifts are indicative of an 
approximately 2 mm error in manually fabricating the lead eSC and Cerrobend eSC apertures. 
 Figure 5.10 specifically addresses the coverage of the 90% dose area.  The areas are 
comparably shaped with the exception of slight differences primarily due to accuracy of the 
beam edges and secondarily due to differences in collimator scatter.  This is reflected in the 
calculated areas listed in Table 5.1.  For 0° the brass area is 4.5% less than that for lead and 2.4% 
less than that for Cerrobend, again attributed to manual fabrication of the lead eSC and 
Cerrobend eSC.  Had the edges been identical, the 90% dose areas would reflect differences due 
only to scatter. 
5.2.3  Penumbral Width 
 The penumbral widths (P80-20) are listed Table 5.2, and the profiles from which they were 
gleaned are plotted in Figure 5.8.  We defined the penumbral width as the lateral distance 
between the 80% and 20% relative dose points along each profile.  The difference in penumbral 
width was very small between the measured fields, 0.5 mm or less (precision was limited to 0.5 
mm due to matrix resolution) for 0° gantry angle.  Upon comparing the penumbral widths of all 
the measured fields and all lateral profile depths, the largest difference was 1.5 mm.  These 
larger differences were for a +3° gantry angle and due to different bevel angles.  This difference 
is not considered to be clinically significant, thus demonstrating the comparable abilities of the 
brass, Cerrobend, and lead as collimating materials. 
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5.2.4  Radiation Leakage 
Radiation leakage through the eSC, which should be primary bremsstrahlung x-rays with 
some secondary electrons, can be appreciated by depth dose curves under the eSCs shown in 
Figure 5.11 and in the off-axis profiles of Figure 5.8.  In Figure 5.8, the surface dose of 
approximately 23% under the brass eSC is a direct result of its being fabricated too thin, i.e., 
primary electrons penetrated the brass.  From 0 to 3 cm, Cerrobend and lead agree well (±0.5%), 
and all three agree at 3 cm and deeper, beyond the range of the primary electrons.  The peak of 
increased dose deeper than 3 cm in Figure 5.8 is due to lateral scatter of the primary electron 
beam, and differences are likely due to the ≤ 1 mm differences in the location of the beam edge, 
e.g., the wider edges for lead give < 2% greater dose, as discussed in section 5.2.2.  There is no 














Figure 5.4:  Isodose plot of the measured dosimetric data collected using the cylindrical 
phantom.  Dosimetric measurements were obtained using radiochromic film with a 16 MeV 
electron beam, at 105 cm SSD, and with a nominally oriented gantry angle (Grel = 0°).  Shown 




Figure 5.4 (continued):   Isodose plot of the measured dosimetric data collected using the 
cylindrical phantom.  Dosimetric measurements were obtained using radiochromic film with a 16 
MeV electron beam, at 105 cm SSD, and with a nominally oriented gantry angle (Grel = 0°).  
Shown are (a) brass eSC, (b) Cerrobend eSC, and (c) lead eSC. 
 
(a)  
Figure 5.5:  Isodose plot of the measured dosimetric data collected using the cylindrical 
phantom.  Dosimetric measurements were obtained using radiochromic film with a 16 MeV 
electron beam, at 105 cm SSD, and with a nominally oriented gantry angle (Grel = +3°).  Shown 








Figure 5.5 (continued):   Isodose plot of the measured dosimetric data collected using the 
cylindrical phantom.  Dosimetric measurements were obtained using radiochromic film with a 16 
MeV electron beam, at 105 cm SSD, and with a nominally oriented gantry angle (Grel = +3°).  






Figure 5.6:  Uniformity within 90% relative dose region taken from the measured dosimetric data 
collected using the cylindrical phantom.  The three subplots on the left correspond to a relative 
gantry angle of 0°, while those on the right correspond to a relative gantry angle of +3°.  The top 
row is the measured distributions of the brass eSC, the second row is the Cerrobend eSC, and the 
bottom row is the Lead eSC.  The relative dose value for each pixel in each plot was mapped to a 
color with respect to the color bar at the bottom of the figure.  As expected, an increase in 




























Figure 5.7:  Differential dose area histogram within 90% dose region taken from the measured 
dosimetric data collected using the cylindrical phantom.  The red, blue, and green lines 
correspond to the relative dose within the 90% region for the brass eSC, Cerrobend eSC, and 
lead eSC measurements, respectively.  For this plot, each pixel with a value ≥90% relative dose 
was placed into the appropriate bin between 90% and 115% relative dose (bin size = 1% relative 
dose).  The number of points (or pixels) in each bin was then normalized based on the total 
number of points ≥90% relative dose in the distribution measured with the lead eSC, which was 
considered the prevailing standard of care and used as a standard of comparison for the 
measurements collected with the three eSCs on the cylindrical phantom.  This plot demonstrates 
that, while the Cerrobend and lead eSCs produced more points within the 100% to 105% relative 
dose interval than the brass eSC, the brass eSC resulted in more points beyond approximately 
105%.  Furthermore, as the relative number of points for the Cerrobend and lead eSC 
distributions falls to near zero around 106%, the line representing the brass eSC distribution 
reaches approximately 113% before reaching the same level. 
 
Table 5.1:  Quantitative comparisons of cylindrical phantom data—depth of R90, 90% relative 
dose area, and maximum relative dose (near the left eSC edge, right eSC edge, and an average of 
both sides).  The three eSCs yielded similar values for the listed quantities.   
 
Field Description








dose [%]     
(left of CAX)
max relative 





mean relative dose 
within 90% [%] ± σ
Brass eSC, Grel = 0° 51.5 4022.0 4.5% 114.4% 113.5% 113.9% 99.1 ± 4.0
Cerrobend eSC, Grel = 0° 52.0 4123.3 2.1% 117.8% 103.3% 110.6% 98.8 ± 3.5
Lead eSC, Grel = 0° 53.0 4212.5 0.0% 106.1% 107.0% 106.6% 100.1 ± 3.6
Brass eSC, Grel = +3° 50.5 3927.8 6.8% 114.6% 116.0% 114.3% 99 ± 4.1
Cerrobend eSC, Grel = +3° 52.0 4139.8 1.7% 106.2% 102.4% 104.3% 98.3 ± 3.1





Figure 5.8: Profiles taken from the measured dosimetric data collected using the cylindrical 
phantom.  Profile depths = 5 mm (magenta line), 10 mm (blue line), 20 mm (green line), and 30 
mm (red line).  Shown are the profiles for the brass eSC (top row), the Cerrobend eSC (middle 
row), and the lead eSC (bottom row).  For each of the three eSCs, profiles are shown for 
































Table 5.2:  Penumbral widths measured from data collected with the cylindrical phantom.  
Provided is a quantitative comparison of penumbral widths of the dose distributions measured 
with the three eSC materials.  These penumbral widths were taken from the lateral profile data 
shown previously in Figure 5.8.  We defined the penumbral width as the lateral distance between 
the 80% and 20% relative dose points along each profile.  The difference in penumbral width 
was very small between the measured fields.  Upon comparing the penumbral widths of all the 




Figure 5.9:  Isodose overlay of the measured dosimetric data collected using the cylindrical 
phantom—brass eSC v. Cerrobend eSC v. lead eSC. Dosimetric measurements were obtained 
using radiochromic film with a 16 MeV electron beam, at 105 cm SSD, and with a nominally 
oriented gantry angle (Grel = 0°).  Displayed in the figure are measured data for the brass eSC 




eSC Material dref = 5 mm dref = 10 mm dref = 20 mm dref = 30 mm
Brass 2.0 2.0 4.5 8.5
Cerrobend 2.0 2.5 4.5 8.5
Lead 1.5 2.0 5.0 8.5
Brass 2.0 3.0 5.0 9.5
Cerrobend 1.5 1.5 4.5 8.5
Lead 1.5 2.0 5.0 9.0
+3





Figure 5.10:  90% relative dose area comparison taken from the measured dosimetric data 
collected using the cylindrical phantom—brass eSC v. Cerrobend eSC v. lead eSC.  This plot 
represents the area cover by 90% or greater of the relative dose.  The area shaded in red 
represents the 90% relative dose area of the brass eSC.  The blue line and green line represent the 
90% relative dose areas of the Cerrobend eSC and Lead eSC, respectively. 
 
Figure 5.11:  Leakage profiles taken from measured dosimetric data collected using cylindrical 
phantom.  Shown in the figure are the leakage profiles from the cylindrical phantom measured 
data for the brass eSC (red line), Cerrobend eSC (blue line), and lead eSC (green line).  An 
unexpected amount of leakage was observed with the brass eSC and was determined to have 
been caused by a planning error within the TPS during the design process, which resulted in the 




Chapter 6:  Discussion of Results and Clinical Recommendations 
6.1 Collimating Material 
Summary of Results:   
 The quality of the milled product, its weight, and its overall dosimetry (see section 6.5) is 
clinically comparable to Cerrobend and lead. 
 Brass was shown to be compatible with MVCT imaging for validating the shape of the 
machined eSC.  It gave comparable results to that of the kVCT images of the wax replica 
and manual measurements. 
Discussion of Results:  Brass was selected as the eSC material for the present study because of a 
need for a dense metal that is easily machined.  Ma et al. (2000) studied the suitability of 
multiple metals using Monte Carlo calculations to study photon and electron fluence under 1.5 
cm of zinc, copper, lead, and tungsten, and these results showed comparable leakage if scaled by 
density.  Potential advantages of the denser materials could be less bremsstrahlung leakage if the 
higher density material were used for constant thicknesses; however, this would result in 
additional weight (potential discomfort).  Also, neither lead nor tungsten is easily milled, and 
toxicity is a concern with milling Cerrobend (lead alloy).   
Clinical Recommendation:  The durability of brass and similar dosimetry of brass relative to 
lead and Cerrobend make it an excellent potential candidate for machined eSC. 
6.2 Bevel Angle and Collimator Scatter (Aim 1) 
Summary of Results: 
 Regardless of the eSC bevel angle (ϴB = 0°, ±10°), the edge of the beam (50% Off-Axis 
Ratio at R100) was defined by the divergence of the beam (accounting for gantry angle) 
and the inner-most, beam-defining edge of the eSC (cf. Figure 2.5). 
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 The penumbral width (P80-20) was the least for bevel angles of 0° and +10° and varies 
insignificantly (±0.5mm) with gantry angle (ϴG = 0°, ±3°, ±5°) (cf. Table 3.4). 
 Increased scatter from the eSC (relative to ϴB = 0°, ϴG = 0°; reference condition of 
OARmax = 103.5% at 5 mm depth) was greatest for a bevel angle of +10° with gantry 
angles of 0° and +5°, where the OAR was as great as 111% (cf. Figure 3.13).  Because of 
the low percentage depth-dose of the 6 MeV beam, the dose never exceeded 100% (cf. 
Figures 3.8-3.10; Figure 3.11). 
 Although scatter impacted the 90% relative dose area (cf. Table 3.2), this primarily 
impacted the proximal portion of the 90% region.  The depth to the distal 90% contour 
remained essentially unchanged (cf. Table 3.3 for central-axis R90 comparisons). 
Discussion of Results:  Electron scatter from the edge of an eSC is complex, depending on 
energy, depth , angle of bevel, and direction of electrons striking the eSC edge.  Results here are 
comparable with others.  Lax and Brahme (1980) observed a 109% OAR near the field edge for 
10.5 MeV electrons (depth = 1 mm) due to scatter from the eSC edge (ϴB = 0°, ϴG = 0°, eSC 
edge on central axis).The most comparable geometry in the present study (ϴB = 0°, ϴG = -3°) 
showed a 106% OAR for 6 MeV electrons.  Verhaegen et al. (2001) observed a peak dose of 
approximately 103% at 6 MeV, and they saw the lobe of scatter dose emitted about 60° from the 
central axis direction, both consistent with the present data.  Chi et al. (2005) observed a similar 
increase in dose near the eSC edge at a depth of 0.5 cm for a 15 MeV electron beam, which 
diminished with depth. 
 Due to the low surface dose (i.e., slow percent depth-dose buildup), there was no clinically 
relevant increase in dose, and in some cases, the increase in the 90% relative dose area could be 
beneficial.  Also, the -10° bevel angle needlessly increased P80-20 by approximately 1 mm.  In 
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addition, the proximal edge of eSC with a negative bevel angle can shield 1-2 mm of the 
intended treatment field, whereas for 0° and positive bevel angles, the field edge is defined by 
the distal eSC edge. 
Clinical Recommendations:  For low energy beams (low surface dose), the eSC bevel angle is 
recommended to be between 0° and +10°, with +10° being more preferable if gantry angle is 
expected to be adjusted. 
6.3 Collimator Thickness (Aim 2 and 3) 
Summary of Results:   
 Aim 2:  MVCT and physical measurement of the brass eSC showed thickness variations 
within -1.5 and +1.0 mm (i.e., ±1.5 mm) of the thickness designed within the TPS (cf. 
Table 4.1).  Variations could be due to the TPS and/or the milling process. 
 Aim 3:  9 mm of brass (typical thickness of brass eSC) was insufficient for stopping 16 
MeV (Ep,0 = 15.9 MeV) electrons, resulting in electrons penetrating approximately 2.25 
cm in the HIWO polystyrene cylindrical phantom (cf. Figure 5.11).  2.25 cm of 
polystyrene corresponds to an electron energy of approximately 4.5 MeV, which requires 
an additional 2.9 mm of brass to stop, i.e., 11.9 mm of brass. 
Discussion of Results:  For brass at 16 MeV, a minimum thickness (tbrass) of 10.7 mm is 
required, according to equation 2.3, without safety margin.  This is not consistent with dose 
measurements under brass by Hogstrom et al. (1985) (at 17.8 MeV, tbrass = 12.7 mm, which 
scales to 11.4 mm for 16 MeV).  The values of 11.4 and 11.9 mm of brass at 16 MeV indicate 
that the calculated lead thickness is more reasonably scaled by a factor of 1.43 (i.e., tbrass = 1.43 × 
tPb).  This increase of 1.3 to 1.43 is believed to be due to less multiple scattering per unit energy 
occurring within the brass. 
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Clinical Recommendations:  To account for a 1.5 mm uncertainty in the eSC design and 
milling process and the decreased multiple scattering, the brass eSC thickness should be 
determined by the following equation: 
      [  ]  (
 
 
     [   ]         )        (6.1), 
6.4 Validation of Fabrication of Brass eSC (Aim 2) 
Summary of Results: 
 MVCT images of the brass eSC and kVCT images of its wax replica provided similar 
results for verification of dimensional agreement of the eSC fabrication with the eSC 
design. 
 MVCT and kVCT results agreed well with physical observations and measurements  
 A variation in thickness of approximately ±1.5 mm was seen in the brass eSC (cf. Table 
4.1). 
 The distal surface of the eSC fit the skin surface well, within 2 mm of design. 
 The eSC aperture edge had up to a 3 mm deviation from the eSC design, which is 
clinically relevant in 2 of the 3 tested eSCs.  The edge of the other was within 0.5 mm. 
Discussion of Results:  The machined brass eSC matched the design relatively well.  The distal 
surface fit well, and the thickness was within ±1.5 mm.  The aperture edge had the correct shape, 
but incorrect divergence, in some cases back-projecting to a virtual source located 20 cm or less 
from the eSC.  The origin of this error was unknown. 
Clinical Recommendations:  It is recommended that there be a QA procedure to validate the 
eSC dimensions—thickness, bevel angle, aperture, and distal surface.  This could be performed 
manually by: [a] fitting eSC on the patient; [b] validating correct aperture shape by comparison 
with skin markings; [c] having sufficient outer margin (≥ 2 cm outside of light field); and [d] 
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measuring thickness and bevel angle.  Alternatively, MVCT could be used and compared with 
the TPS design contour.  The MVCT could be either on the patient (cf. Figures 4.6 & 4.8) or in 
air (cf. Figure 4.7). 
6.5 Dosimetric Equivalence of Brass eSC (Aim 3) 
Summary of Results:  Overall, there was good dosimetric agreement between identical brass, 
lead, and Cerrobend eSCs: 
 Impact of collimator scattered dose—increased dose (3-10%) was observed with brass, 
but that difference decreased to almost 0% at 3 cm depth for the 16 MeV beam (cf. Table 
5.1). 
 Field width and the 90% relative dose region—good agreement was seen in 90% regions; 
there was a slight difference in field width (50% isodose) due to manual fabrication 
methods for lead and Cerrobend eSCs (cf. Figure 5.9). 
 Penumbral width—no significant difference (≤ 0.5 mm) was observed between the three 
eSC materials with a nominal gantry angle (cf. Table 5.2). 
 Radiation leakage—no evidence of any clinical significant difference in leakage dose 
between brass, Cerrobend, and lead (cf. Figure 5.11). 
Discussion of Results:  For the phantom case used in this investigation (16 MeV), the results 
demonstrated that machined brass eSC was dosimetrically comparable to the current standard of 
care, with the exception of increased dose near the aperture edge due to scatter.  Relative to the 
standard of comparison in this study (lead eSC), an increase in scattered electrons was observed 
with the brass eSC, specifically near the eSC edge.  However, the increase in scatter was near the 
surface (0-3 cm) which is partially offset by the buildup of surface dose.  Small volumes of dose 
greater than 105% dose were seen (cf. Figure 5.4 and 5.5).  If important, they could be reduced 
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by better optimizing the collimator bevel.  Only a minor effect on the 90% relative dose region 
was seen.  The eSC material did not have any significant effect on penumbral width. 
Clinical Recommendations:  Results demonstrated brass to be comparable eSC material to 
current standard of care (lead) with the exception of increased scattered dose.  Further 




Chapter 7:  Conclusions 
7.1 Conclusions 
Results of this work indicated that brass eSC holds good potential for replacing lead and 
Cerrobend skin collimation. 
With respect to part 1 of the hypothesis:  “that a third party milled brass eSC with its 
collimating edge parallel to the mean direction of the divergent electron beam is milled 
accurately, i.e., within design parameters” was false.  Results for the three milled brass eSCs 
showed their thickness to be slightly outside ±1 mm (within ±1.5 mm).  Their distal surface 
matched the phantom (“skin”) surface to within 2 mm.  The aperture shapes were within ±0.5 
mm for one eSC.  The other two eSCs were fabricated with a bevel whose divergence appeared 
to be emitted approximately 20 cm above the eSC, as opposed to 105 cm, resulting in variations 
in aperture edge location of up to ±3 mm. 
With respect to part 2 of the hypothesis:  “that it (brass eSC) is dosimetrically equivalent 
to current lead and Cerrobend eSCs with edges parallel to beam central axis and an open bevel 
angle of 10°, respectively.”  The R90 values agreed within 1 mm, and the penumbral width agreed 
within 2 mm.  However, scatter dose from the brass was greater, as much as 10% greater than 
that from lead. 
7.2 Proposed Future Work 
The present study was limited for several reasons: 
1) The results for aim 1 were limited because [1] only 6 MeV was studied, [2] there was 
no comparison with brass, and [3] data analysis was complicated by the edges being 
positioned 5 cm (3°) off-axis, making data on the left and right sides asymmetric 
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because one side the beam divergence increased the angle of the mean direction of the 
electrons with respect to the eSC aperture edge, but decreased it on the opposite side. 
2) The results for aim 2 were limited because two of the three brass eSCs had apertures 
with exaggerated divergence (cause unresolved). 
3) The results for aim 3 were limited because [1] the brass eSC was designed too thin for 
16 MeV electrons, [2] the aperture edge was in error (see 2 above), and [3] only 16 
MeV was studied, an energy not used often with eSC. 
 
Prior to clinical use of brass eSCs, the following 3 studies are recommended: 
1) Collimator Fabrication:  Determine and correct the problem as to why the edges of 
the two brass eSCs were fabricated with too great of a divergence.  Once corrected, 
design new brass eSCs with the new recommended thickness relationship,  
      [  ]  (
 
 
     [   ]         ), 
and validate with MVCT. 
2) Optimal Bevel Angle:  Determine the most appropriate brass eSC bevel angle.  
Repeat 2-D dose measurements/calculations from aim 1 using [1] 6, 9, 12, and 16 
MeV; [2] brass eSC with bevel angles of 0°, 5°, 10°, and 20°; [3] lead eSC with bevel 
angles of 0°, 5°, 10°, and 20°; [4] Cerrobend eSC with bevel angles of 0°, 5°, 10°, and 
20°; [5] with the beveled edge placed on central axis of a 20×20 cm
2
 field; and [6] a 
nominal gantry angle (ϴG = 0°).  2-D diode dose measurements in a water phantom (d 
≥ 5 mm) and Monte Carlo (MC) dose calculations should be performed, and the 
resulting data should be evaluated using similar metrics as the present study.  MC 
calculations should allow the scattered dose component from the eSC to be isolated. 
89 
 
3) eSC with Bolus:  The next logical step toward widely available improvements in 
electron conformal therapy (ECT) would be to use machined eSC to sharpen the 
blurred penumbra beneath a variable-thickness bolus.  The use of bolus ECT is a 
relatively new development in electron therapy and allows for the modulation of the 
electron range to match the distal tumor surface.  Much success has been seen with 
bolus ECT, but one drawback is the blurring of the penumbra as the electrons traverse 
the bolus.  Machined eSCs could be used to restore the penumbral sharpness.  In this 
situation, however, we are, again, faced with the likely prospect that some current 
clinical electron dose algorithms will be unable to provide sufficiently accurate dose 
calculations for an eSC located below the surface of the bolus.  The integration of 
machined eSC with bolus ECT would likely provide significant improvement to 
currently available treatment options and, perhaps, broaden the application of this 
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